,coef,coef_graph,coef_combined,coef_combined_zscore,coef_combined2
5-Phosphoribose 1-diphosphate biosynthesis,1.4138071e-06,2.0,1.4138071e-06,-0.26811224,-0.024276694
ABC transporters in lipid homeostasis,0.0011686452,2.0,0.0011686452,-0.24859188,-0.010163005
ADP signalling through P2Y purinoceptor 1,0.020575121,2.0,0.020575121,0.075954884,0.224492
ADP signalling through P2Y purinoceptor 12,0.021094235,2.0,0.021094235,0.08463635,0.2307689
AKT phosphorylates targets in the cytosol,0.10863009,2.0,0.10863009,1.5485538,1.289216
AKT phosphorylates targets in the nucleus,0.0022835436,2.0,0.0022835436,-0.22994673,0.0033178774
AKT-mediated inactivation of FOXO1A,0.00014724213,2.0,0.00014724213,-0.26567346,-0.022513388
ALKBH2 mediated reversal of alkylation damage,0.001574022,2.0,0.001574022,-0.24181251,-0.0052613523
ALKBH3 mediated reversal of alkylation damage,0.00019500336,2.0,0.00019500336,-0.2648747,-0.021935876
AMER1 mutants destabilize the destruction complex,0.0010203482,3.0,0.0010203482,-0.25107196,-0.6164706
AMPK inhibits chREBP transcriptional activation activity,0.015175275,2.0,0.015175275,-0.014350162,0.15919931
APC/C-mediated degradation of cell cycle proteins,0.0048190644,5.0,0.0048190644,-0.18754362,-1.7795668
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,0.0004107616,2.0,0.0004107616,-0.26126644,-0.019327013
ARL13B-mediated ciliary trafficking of INPP5E,0.0115703875,2.0,0.0115703875,-0.074636966,0.115610525
ATF4 activates genes,0.016706707,2.0,0.016706707,0.01126095,0.17771676
ATF6 (ATF6-alpha) activates chaperone genes,0.023401484,2.0,0.023401484,0.12322194,0.2586672
ATP sensitive Potassium channels,2.4552073e-05,2.0,2.4552073e-05,-0.2677253,-0.023996923
AUF1 (hnRNP D0) binds and destabilizes mRNA,0.039877683,2.0,0.039877683,0.39876384,0.45789057
"AXIN mutants destabilize the destruction complex, activating WNT signaling",0.00014513706,3.0,0.00014513706,-0.26570866,-0.62705326
Abacavir metabolism,0.028973754,2.0,0.028973754,0.21641055,0.3260448
Abacavir transmembrane transport,1.2160657e-05,2.0,1.2160657e-05,-0.2679325,-0.02414673
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,0.0011550904,2.0,0.0011550904,-0.24881856,-0.010326922
Acetylation,0.0,2.0,0.0,-0.26813588,-0.024293775
Acetylcholine Neurotransmitter Release Cycle,8.266946e-08,2.0,8.266946e-08,-0.2681345,-0.024292793
Acetylcholine binding and downstream events,7.6149777e-06,2.0,7.6149777e-06,-0.26800853,-0.024201721
Acetylcholine regulates insulin secretion,0.023897685,2.0,0.023897685,0.13152023,0.26466706
Acrosome Reaction,0.0,2.0,0.0,-0.26813588,-0.024293775
Activated NOTCH1 Transmits Signal to the Nucleus,0.0044236663,2.0,0.0044236663,-0.1941561,0.029195359
Activation and oligomerization of BAK protein,0.000295579,2.0,0.000295579,-0.2631927,-0.020719755
Activation of ATR in response to replication stress,0.002887072,2.0,0.002887072,-0.21985355,0.01061549
Activation of BH3-only proteins,0.006057647,6.0,0.006057647,-0.16683002,-2.3691046
Activation of C3 and C5,0.0,2.0,0.0,-0.26813588,-0.024293775
Activation of Matrix Metalloproteinases,0.0009033231,2.0,0.0009033231,-0.25302902,-0.013371178
Activation of NMDA receptor and postsynaptic events,0.00084979663,3.0,0.00084979663,-0.2539242,-0.6185328
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,0.00028805123,2.0,0.00028805123,-0.26331863,-0.020810781
Activation of RAC1,4.1664716e-06,2.0,4.1664716e-06,-0.2680662,-0.024243396
Activation of SMO,2.3137349e-05,2.0,2.3137349e-05,-0.26774892,-0.024014005
Activation of anterior HOX genes in hindbrain development during early embryogenesis,0.013968847,2.0,0.013968847,-0.034526017,0.14461169
Activation of kainate receptors upon glutamate binding,0.0006117578,3.0,0.0006117578,-0.25790507,-0.621411
Activation of the pre-replicative complex,0.00082272483,2.0,0.00082272483,-0.25437692,-0.01434574
"Activation, myristolyation of BID and translocation to mitochondria",0.01977889,2.0,0.01977889,0.06263902,0.21486431
"Activation, translocation and oligomerization of BAX",0.008171339,2.0,0.008171339,-0.13148141,0.07451064
Adherens junctions interactions,0.0024381017,2.0,0.0024381017,-0.22736196,0.005186729
Adrenaline signalling through Alpha-2 adrenergic receptor,0.00055059354,2.0,0.00055059354,-0.25892797,-0.017636223
"Adrenaline,noradrenaline inhibits insulin secretion",0.0587031,2.0,0.0587031,0.7135932,0.68551964
Advanced glycosylation endproduct receptor signaling,0.00010704539,2.0,0.00010704539,-0.26634568,-0.022999428
Aflatoxin activation and detoxification,0.010326357,2.0,0.010326357,-0.095441684,0.10056822
Agmatine biosynthesis,0.005807775,2.0,0.005807775,-0.17100878,0.045931414
Amine Oxidase reactions,0.0,3.0,0.0,-0.26813588,-0.62880814
Amino Acid conjugation,6.7257474e-07,2.0,6.7257474e-07,-0.26812464,-0.024285655
Amino acid transport across the plasma membrane,3.8072805e-05,2.0,3.8072805e-05,-0.26749918,-0.023833428
Amplification of signal from the kinetochores,0.011260108,2.0,0.011260108,-0.07982597,0.111858755
Amyloid fiber formation,0.021993622,2.0,0.021993622,0.09967738,0.24164394
Anchoring fibril formation,0.0,2.0,0.0,-0.26813588,-0.024293775
Anchoring of the basal body to the plasma membrane,0.0006050056,2.0,0.0006050056,-0.258018,-0.016978309
Antagonism of Activin by Follistatin,0.02581809,2.0,0.02581809,0.16363639,0.2878878
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0.00043321043,2.0,0.00043321043,-0.26089102,-0.019055571
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,0.00089686963,2.0,0.00089686963,-0.25313696,-0.013449217
Antigen processing-Cross presentation,3.759681e-05,5.0,3.759681e-05,-0.2675071,-1.8373823
Antigen processing: Ubiquitination & Proteasome degradation,0.00384571,2.0,0.00384571,-0.20382163,0.022206942
Antiviral mechanism by IFN-stimulated genes,0.0009316978,2.0,0.0009316978,-0.2525545,-0.013028087
Apoptosis induced DNA fragmentation,0.010565123,2.0,0.010565123,-0.09144865,0.103455275
Apoptotic cleavage of cellular proteins,0.008391916,4.0,0.008391916,-0.12779257,-1.1318508
Apoptotic factor-mediated response,0.0070136604,3.0,0.0070136604,-0.15084201,-0.54400194
Arachidonate production from DAG,2.6613307e-05,2.0,2.6613307e-05,-0.2676908,-0.023971979
Arachidonic acid metabolism,0.06009078,9.0,0.0066767535,-0.15647629,-3.5293016
Aryl hydrocarbon receptor signalling,0.000249424,2.0,0.000249424,-0.26396462,-0.02127787
Assembly of active LPL and LIPC lipase complexes,0.02103649,2.0,0.02103649,0.08367066,0.2300707
Assembly of the pre-replicative complex,3.515798e-05,4.0,3.515798e-05,-0.2675479,-1.2328973
Association of TriC/CCT with target proteins during biosynthesis,0.052217703,2.0,0.052217703,0.6051338,0.6071009
Astrocytic Glutamate-Glutamine Uptake And Metabolism,9.428455e-05,2.0,9.428455e-05,-0.2665591,-0.023153728
Attachment of GPI anchor to uPAR,0.0002821825,2.0,0.0002821825,-0.26341674,-0.020881731
B-WICH complex positively regulates rRNA expression,0.0014730212,2.0,0.0014730212,-0.24350162,-0.006482632
BBSome-mediated cargo-targeting to cilium,0.0026791277,2.0,0.0026791277,-0.22333112,0.008101115
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,1.6387694e-05,2.0,1.6387694e-05,-0.2678618,-0.024095625
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",0.000834755,2.0,0.000834755,-0.25417575,-0.014200263
Basigin interactions,0.072932914,2.0,0.072932914,0.95156735,0.85758066
Beta-catenin phosphorylation cascade,0.007184121,2.0,0.007184121,-0.14799128,0.06257361
Bicarbonate transporters,0.00019725355,2.0,0.00019725355,-0.26483706,-0.021908661
Bile acid and bile salt metabolism,0.007927503,3.0,0.007927503,-0.13555922,-0.5329521
Biosynthesis of DHA-derived SPMs,0.0020425776,6.0,0.0020425776,-0.23397656,-2.4176533
Biosynthesis of DPA-derived SPMs,0.0055256123,3.0,0.0055256123,-0.17572756,-0.56199473
Biosynthesis of EPA-derived SPMs,0.0054993588,3.0,0.0054993588,-0.17616661,-0.5623122
Biosynthesis of electrophilic Ï‰-3 PUFA oxo-derivatives,0.0056616985,2.0,0.0056616985,-0.17345172,0.044165112
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",0.0,1.0,0.0,-0.26813588,0.58022064
Biotin transport and metabolism,0.14664568,2.0,0.14664568,2.1843126,1.7488847
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,0.04719662,2.0,0.04719662,0.52116305,0.5463881
Butyrophilin (BTN) family interactions,0.003614229,2.0,0.003614229,-0.20769283,0.019407976
C6 deamination of adenosine,0.0007113169,2.0,0.0007113169,-0.25624007,-0.01569283
CD209 (DC-SIGN) signaling,0.001187211,2.0,0.001187211,-0.2482814,-0.009938518
CD22 mediated BCR regulation,0.0009905029,2.0,0.0009905029,-0.2515711,-0.012317032
CD28 co-stimulation,0.00027987326,3.0,0.00027987326,-0.26345536,-0.625424
CDK-mediated phosphorylation and removal of Cdc6,0.11503135,2.0,0.11503135,1.655606,1.3666173
CDO in myogenesis,0.019731613,2.0,0.019731613,0.061848365,0.21429266
CHL1 interactions,0.0009358163,2.0,0.0009358163,-0.25248563,-0.012978269
CLEC7A (Dectin-1) signaling,0.005371637,4.0,0.005371637,-0.17830259,-1.1683708
COPI-mediated anterograde transport,0.00034298943,2.0,0.00034298943,-0.26239985,-0.020146502
COPII-mediated vesicle transport,0.00033222925,2.0,0.00033222925,-0.2625798,-0.020276606
COX reactions,0.0,2.0,0.0,-0.26813588,-0.024293775
CREB3 factors activate genes,0.013730303,2.0,0.013730303,-0.03851533,0.14172731
CRMPs in Sema3A signaling,0.000519288,2.0,0.000519288,-0.2594515,-0.018014764
CTLA4 inhibitory signaling,0.0014869516,2.0,0.0014869516,-0.24326864,-0.0063141873
Ca2+ activated K+ channels,0.00033953952,2.0,0.00033953952,-0.26245755,-0.020188201
Ca2+ pathway,0.002861862,2.0,0.002861862,-0.22027515,0.010310659
CaM pathway,0.007203811,2.0,0.007203811,-0.14766198,0.062811695
Cap-dependent Translation Initiation,0.51591474,7.0,0.51591474,8.359833,3.191361
Carboxyterminal post-translational modifications of tubulin,0.0025940586,2.0,0.0025940586,-0.2247538,0.0070724874
Cargo concentration in the ER,0.00021940218,2.0,0.00021940218,-0.26446667,-0.021640848
Cargo recognition for clathrin-mediated endocytosis,0.0007099437,2.0,0.0007099437,-0.25626305,-0.015709445
Carnitine synthesis,0.0022959283,2.0,0.0022959283,-0.22973962,0.0034676257
Catecholamine biosynthesis,0.0019456715,2.0,0.0019456715,-0.23559718,-0.0007675257
Cation-coupled Chloride cotransporters,0.00021500945,2.0,0.00021500945,-0.26454014,-0.021693991
"Cell death signalling via NRAGE, NRIF and NADE",0.024456501,4.0,0.024456501,0.14086565,-0.9376046
Cellular hexose transport,0.0047590695,2.0,0.0047590695,-0.18854694,0.0332509
Ceramide signalling,0.003005018,2.0,0.003005018,-0.21788105,0.012041649
ChREBP activates metabolic gene expression,2.6367767e-05,2.0,2.6367767e-05,-0.26769492,-0.023974951
Cholesterol biosynthesis,0.025351789,3.0,0.025351789,0.15583812,-0.3222649
Choline catabolism,0.0110795945,2.0,0.0110795945,-0.08284481,0.109676056
Chondroitin sulfate/dermatan sulfate metabolism,0.012827648,5.0,0.012827648,-0.053611007,-1.6827303
Chylomicron assembly,7.5832025e-07,2.0,7.5832025e-07,-0.2681232,-0.024284625
Chylomicron clearance,2.3775506e-07,2.0,2.3775506e-07,-0.26813188,-0.024290897
Chylomicron remodeling,0.004856119,2.0,0.004856119,-0.18692392,0.03442439
Citric acid cycle (TCA cycle),0.066751756,2.0,0.066751756,0.84819597,0.78284067
Class A/1 (Rhodopsin-like receptors),0.047451675,10.0,0.0047451677,-0.18877943,-4.2866426
Class B/2 (Secretin family receptors),0.003335358,3.0,0.003335358,-0.21235657,-0.5884784
Class C/3 (Metabotropic glutamate/pheromone receptors),0.0062314365,2.0,0.0062314365,-0.16392362,0.05105415
Classical Kir channels,0.0032796215,2.0,0.0032796215,-0.2132887,0.015362036
Clathrin derived vesicle budding,0.00013670608,3.0,0.00013670608,-0.26584965,-0.6271552
Cleavage of Growing Transcript in the Termination Region ,0.019908095,2.0,0.019908095,0.064799786,0.2164266
"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.06022823,2.0,0.06022823,0.7390989,0.70396084
Collagen chain trimerization,0.005300566,2.0,0.005300566,-0.17949115,0.039798465
Collagen degradation,0.008884707,2.0,0.008884707,-0.11955131,0.083136395
Common Pathway of Fibrin Clot Formation,0.019508878,2.0,0.019508878,0.058123425,0.21159944
Constitutive Signaling by AKT1 E17K in Cancer,0.0015842554,2.0,0.0015842554,-0.24164137,-0.005137613
Constitutive Signaling by Aberrant PI3K in Cancer,0.04363798,2.0,0.04363798,0.46164966,0.5033585
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,0.090092644,2.0,0.090092644,1.2385404,1.065069
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,0.0472419,4.0,0.0472419,0.5219203,-0.66209316
Creatine metabolism,0.32309735,2.0,0.32309735,5.1352253,3.8824651
Cristae formation,0.0035442377,2.0,0.0035442377,-0.20886335,0.018561658
Crosslinking of collagen fibrils,8.674536e-06,2.0,8.674536e-06,-0.2679908,-0.024188897
Cyclin A:Cdk2-associated events at S phase entry,0.027374743,2.0,0.027374743,0.18966925,0.30671018
Cysteine formation from homocysteine,0.0001457051,2.0,0.0001457051,-0.26569915,-0.022531968
Cytochrome P450 - arranged by substrate type,0.009720985,7.0,0.009720985,-0.1055657,-2.9293234
Cytosolic iron-sulfur cluster assembly,0.0059983316,2.0,0.0059983316,-0.16782197,0.04823555
Cytosolic sulfonation of small molecules,8.93999e-05,2.0,8.93999e-05,-0.26664078,-0.02321279
Cytosolic tRNA aminoacylation,0.062892064,2.0,0.062892064,0.7836479,0.7361709
DAP12 signaling,0.0005460518,2.0,0.0005460518,-0.2590039,-0.017691165
DCC mediated attractive signaling,0.0025439125,2.0,0.0025439125,-0.22559242,0.006466147
DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,0.0027853262,2.0,0.0027853262,-0.22155511,0.009385224
DNA Damage Recognition in GG-NER,0.0009185548,2.0,0.0009185548,-0.2527743,-0.013186997
DNA Damage/Telomere Stress Induced Senescence,0.000514852,2.0,0.000514852,-0.2595257,-0.018068397
DNA methylation,0.015808567,2.0,0.015808567,-0.0037592053,0.16685683
DNA replication initiation,9.834744e-05,2.0,9.834744e-05,-0.26649114,-0.023104612
DSCAM interactions,0.00034522437,2.0,0.00034522437,-0.26236248,-0.020119475
Deactivation of the beta-catenin transactivating complex,0.0022648042,2.0,0.0022648042,-0.23026012,0.0030912838
Deadenylation of mRNA,0.7466166,2.0,0.7466166,12.218006,9.003484
Dectin-2 family,0.00044448956,2.0,0.00044448956,-0.2607024,-0.018919198
Defective ABCA1 causes Tangier disease,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2,0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCC2 causes Dubin-Johnson syndrome,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCC6 causes pseudoxanthoma elasticum (PXE),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCC8 can cause hypoglycemias and hyperglycemias,2.6115325e-05,2.0,2.6115325e-05,-0.26769912,-0.023977993
"Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCD1 causes adrenoleukodystrophy (ALD),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCG5 causes sitosterolemia,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ABCG8 causes gallbladder disease 4 and sitosterolemia,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD),0.0004132231,2.0,0.0004132231,-0.26122528,-0.01929727
Defective ACY1 causes encephalopathy,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG1 causes ALG1-CDG (CDG-1k),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG11 causes ALG11-CDG (CDG-1p),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG12 causes ALG12-CDG (CDG-1g),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG2 causes ALG2-CDG (CDG-1i),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG3 causes ALG3-CDG (CDG-1d),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG6 causes ALG6-CDG (CDG-1c),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG8 causes ALG8-CDG (CDG-1h),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ALG9 causes ALG9-CDG (CDG-1l),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective AVP causes neurohypophyseal diabetes insipidus (NDI),0.004889911,2.0,0.004889911,-0.1863588,0.034832988
Defective AVP causes neurohypophyseal diabetes insipidus (NDI),0.004889911,2.0,0.004889911,-0.1863588,0.034832988
Defective AVP causes neurohypophyseal diabetes insipidus (NDI),3.880117e-07,2.0,3.880117e-07,-0.2681294,-0.024289096
Defective AVP causes neurohypophyseal diabetes insipidus (NDI),3.880117e-07,2.0,3.880117e-07,-0.2681294,-0.024289096
Defective B3GALT6 causes EDSP2 and SEMDJL1,0.0060430192,2.0,0.0060430192,-0.16707465,0.04877588
Defective B3GALTL causes Peters-plus syndrome (PpS),0.010093632,2.0,0.010093632,-0.09933368,0.09775422
Defective B3GAT3 causes JDSSDHD,0.018855631,2.0,0.018855631,0.047198772,0.20370065
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),0.0003899418,2.0,0.0003899418,-0.26161465,-0.019578772
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),0.0003899418,2.0,0.0003899418,-0.26161465,-0.019578772
"Defective B4GALT7 causes EDS, progeroid type",0.0051216516,2.0,0.0051216516,-0.18248326,0.0376351
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),3.2536354e-05,2.0,3.2536354e-05,-0.26759174,-0.023900352
Defective CFTR causes cystic fibrosis,0.06352443,2.0,0.06352443,0.79422337,0.7438172
"Defective CHST14 causes EDS, musculocontractural type",1.219071e-07,2.0,1.219071e-07,-0.26813385,-0.024292326
Defective CHST3 causes SEDCJD,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CHST6 causes MCDC1,0.0019351402,2.0,0.0019351402,-0.2357733,-0.0008948684
Defective CHSY1 causes TPBS,3.9197542e-07,2.0,3.9197542e-07,-0.26812935,-0.02428905
Defective CP causes aceruloplasminemia (ACERULOP),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4),0.00035482904,2.0,0.00035482904,-0.26220185,-0.020003341
Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5),0.015835198,2.0,0.015835198,-0.003313851,0.16717882
"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)",0.001244849,2.0,0.001244849,-0.2473175,-0.009241596
Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP19A1 causes Aromatase excess syndrome (AEXS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP1B1 causes Glaucoma,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)",0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)",0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective DHDDS causes retinitis pigmentosa 59,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective DOLK causes DOLK-CDG (CDG-1m),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective DPM1 causes DPM1-CDG (CDG-1e),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective DPM2 causes DPM2-CDG (CDG-1u),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective DPM3 causes DPM3-CDG (CDG-1o),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",0.0013428053,2.0,0.0013428053,-0.2456793,-0.008057147
Defective EXT2 causes exostoses 2,0.008545695,2.0,0.008545695,-0.12522082,0.0790372
Defective FMO3 causes Trimethylaminuria (TMAU),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GALE can cause Epimerase-deficiency galactosemia (EDG),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GALK1 can cause Galactosemia II (GALCT2),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GALNT12 causes colorectal cancer 1 (CRCS1),2.6614403e-05,2.0,2.6614403e-05,-0.2676908,-0.023971979
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),0.00072643306,2.0,0.00072643306,-0.25598726,-0.015510053
Defective GALT can cause Galactosemia,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GCK causes maturity-onset diabetes of the young 2 (MODY2),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GFPT1 causes CMSTA1,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GGT1 causes Glutathionuria (GLUTH),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GGT1 causes Glutathionuria (GLUTH),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GGT1 causes Glutathionuria (GLUTH),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GGT1 causes Glutathionuria (GLUTH),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective GSS causes Glutathione synthetase deficiency (GSS deficiency),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective HEXA causes GM2G1,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective HEXB causes GM2G2,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective HK1 causes hexokinase deficiency (HK deficiency),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective LARGE causes MDDGA6 and MDDGB6,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective LFNG causes SCDO3,0.001392502,2.0,0.001392502,-0.24484818,-0.0074562235
Defective MAN1B1 causes MRT15,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective MAOA causes Brunner syndrome (BRUNS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective MGAT2 causes MGAT2-CDG (CDG-2a),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective MOGS causes MOGS-CDG (CDG-2b),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective MPDU1 causes MPDU1-CDG (CDG-1f),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective MPI causes MPI-CDG (CDG-1b),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective Mismatch Repair Associated With MLH1,0.0016109752,2.0,0.0016109752,-0.24119452,-0.0048145293
Defective Mismatch Repair Associated With MSH2,0.00021402845,2.0,0.00021402845,-0.26455653,-0.02170583
Defective Mismatch Repair Associated With MSH3,0.00015948826,2.0,0.00015948826,-0.26546863,-0.022365313
Defective Mismatch Repair Associated With MSH6,0.0021485905,2.0,0.0021485905,-0.23220363,0.0016860913
Defective Mismatch Repair Associated With PMS2,0.0049957247,2.0,0.0049957247,-0.18458922,0.036112428
Defective NEU1 causes sialidosis,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective PAPSS2 causes SEMD-PA,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective PGM1 causes PGM1-CDG (CDG1t),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective PMM2 causes PMM2-CDG (CDG-1a),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",0.0004999122,2.0,0.0004999122,-0.25977552,-0.018249068
"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",0.00024141755,2.0,0.00024141755,-0.2640985,-0.02137465
"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",0.0029191282,2.0,0.0029191282,-0.21931745,0.011003099
Defective RFT1 causes RFT1-CDG (CDG-1n),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC12A1 causes Bartter syndrome 1 (BS1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC12A3 causes Gitelman syndrome (GS),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC17A5 causes Salla disease (SD) and ISSD,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC1A3 causes episodic ataxia 6 (EA6),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC22A12 causes renal hypouricemia 1 (RHUC1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC26A2 causes chondrodysplasias,0.0,3.0,0.0,-0.26813588,-0.62880814
Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC26A4 causes Pendred syndrome (PDS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC2A10 causes arterial tortuosity syndrome (ATS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC2A9 causes hypouricemia renal 2 (RHUC2),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC33A1 causes spastic paraplegia 42 (SPG42),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC3A1 causes cystinuria (CSNU),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC5A2 causes renal glucosuria (GLYS1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A19 causes Hartnup disorder (HND),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A19 causes Hartnup disorder (HND),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A19 causes Hartnup disorder (HND),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A19 causes Hartnup disorder (HND),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A2 causes orthostatic intolerance (OI),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC6A5 causes hyperekplexia 3 (HKPX3),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC7A7 causes lysinuric protein intolerance (LPI),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC7A9 causes cystinuria (CSNU),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SLC9A9 causes autism 16 (AUTS16),0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",0.0,2.0,0.0,-0.26813588,-0.024293775
"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",4.2471074e-06,2.0,4.2471074e-06,-0.26806486,-0.024242437
"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",4.2471074e-06,2.0,4.2471074e-06,-0.26806486,-0.024242437
"Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",2.6623238e-07,2.0,2.6623238e-07,-0.26813143,-0.02429057
"Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",0.0,2.0,0.0,-0.26813588,-0.024293775
Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective ST3GAL3 causes MCT12 and EIEE15,0.0030798463,2.0,0.0030798463,-0.21662965,0.012946445
Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency),0.0,2.0,0.0,-0.26813588,-0.024293775
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),3.508751e-05,2.0,3.508751e-05,-0.2675491,-0.023869533
Defective UGT1A1 causes hyperbilirubinemia,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective UGT1A4 causes hyperbilirubinemia,0.0,2.0,0.0,-0.26813588,-0.024293775
Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS),0.04898866,2.0,0.04898866,0.55113244,0.56805664
Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS),0.00080579345,2.0,0.00080579345,-0.25466007,-0.014550467
Defects in biotin (Btn) metabolism,0.005659463,3.0,0.005659463,-0.1734891,-0.5603763
Defects in cobalamin (B12) metabolism,0.0069330023,15.0,0.00046220014,-0.2604062,-7.7991495
Defensins,0.00011298614,3.0,0.00011298614,-0.26624635,-0.627442
Degradation of AXIN,0.00034081598,2.0,0.00034081598,-0.2624362,-0.02017278
Degradation of DVL,0.0088712,2.0,0.0088712,-0.119777195,0.08297307
Degradation of GLI1 by the proteasome,0.00022719234,2.0,0.00022719234,-0.2643364,-0.021546664
Degradation of GLI2 by the proteasome,0.0036652854,2.0,0.0036652854,-0.206839,0.020025326
Degradation of cysteine and homocysteine,0.0001107884,2.0,0.0001107884,-0.2662831,-0.022954173
Deposition of new CENPA-containing nucleosomes at the centromere,0.016912721,2.0,0.016912721,0.014706255,0.18020779
Depurination,2.3284086e-07,3.0,2.3284086e-07,-0.26813197,-0.62880534
Depyrimidination,0.009789649,3.0,0.009789649,-0.104417376,-0.51043576
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.083552085,2.0,0.083552085,1.1291585,0.9859832
Detoxification of Reactive Oxygen Species,0.0010647849,2.0,0.0010647849,-0.2503288,-0.011418847
Digestion of dietary carbohydrate,0.011384331,2.0,0.011384331,-0.077748515,0.1133608
Digestion of dietary lipid,0.0008416217,2.0,0.0008416217,-0.25406092,-0.01411724
Disassembly of the destruction complex and recruitment of AXIN to the membrane,0.0006311704,2.0,0.0006311704,-0.25758043,-0.01666194
Disinhibition of SNARE formation,0.04754333,2.0,0.04754333,0.52696127,0.5505803
Displacement of DNA glycosylase by APEX1,0.026130524,2.0,0.026130524,0.16886139,0.2916656
Dissolution of Fibrin Clot,0.0011892963,2.0,0.0011892963,-0.24824652,-0.009913292
Dopamine Neurotransmitter Release Cycle,7.4967946e-05,2.0,7.4967946e-05,-0.26688215,-0.023387307
Dopamine clearance from the synaptic cleft,0.00012543207,3.0,0.00012543207,-0.26603818,-0.62729144
Downregulation of ERBB2 signaling,0.00040185876,2.0,0.00040185876,-0.26141533,-0.019434676
Downregulation of ERBB4 signaling,0.00030252768,2.0,0.00030252768,-0.2630765,-0.02063575
Downstream TCR signaling,0.008108702,2.0,0.008108702,-0.13252893,0.07375326
Downstream signal transduction,0.000301955,2.0,0.000301955,-0.26308608,-0.020642653
Downstream signaling events of B Cell Receptor (BCR),0.00042107984,4.0,0.00042107984,-0.26109388,-1.228231
Dual Incision in GG-NER,0.050466117,2.0,0.050466117,0.5758409,0.58592147
Dual incision in TC-NER,0.039379403,2.0,0.039379403,0.39043078,0.45186552
E3 ubiquitin ligases ubiquitinate target proteins,0.008962582,2.0,0.008962582,-0.118248954,0.08407802
ECM proteoglycans,0.13902552,2.0,0.13902552,2.056876,1.6567451
EGFR downregulation,0.036202125,2.0,0.036202125,0.33729517,0.41344726
EGFR interacts with phospholipase C-gamma,0.0066754925,2.0,0.0066754925,-0.15649739,0.056423496
EPH-ephrin mediated repulsion of cells,0.0011476557,2.0,0.0011476557,-0.2489429,-0.010416801
EPHA-mediated growth cone collapse,0.00029722412,2.0,0.00029722412,-0.2631652,-0.020699866
EPHB-mediated forward signaling,2.9435532e-05,2.0,2.9435532e-05,-0.2676436,-0.023937862
ERBB2 Activates PTK6 Signaling,0.007237034,3.0,0.007237034,-0.14710638,-0.54130095
ERBB2 Regulates Cell Motility,0.11755415,2.0,0.11755415,1.6977966,1.397122
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,0.014920761,2.0,0.014920761,-0.018606555,0.15612184
Electric Transmission Across Gap Junctions,0.0028490631,2.0,0.0028490631,-0.22048919,0.010155903
Electron transport from NADPH to Ferredoxin,0.008655478,2.0,0.008655478,-0.12338484,0.08036465
Elevation of cytosolic Ca2+ levels,0.0022731693,2.0,0.0022731693,-0.23012023,0.0031924301
Endosomal Sorting Complex Required For Transport (ESCRT),0.0005296576,2.0,0.0005296576,-0.25927806,-0.017889388
Energy dependent regulation of mTOR by LKB1-AMPK,0.0004104661,2.0,0.0004104661,-0.2612714,-0.019330593
Ephrin signaling,7.42857e-06,2.0,7.42857e-06,-0.26801166,-0.024203967
Erythrocytes take up carbon dioxide and release oxygen,0.00078024785,2.0,0.00078024785,-0.2550873,-0.014859347
Erythrocytes take up oxygen and release carbon dioxide,6.257195e-05,2.0,6.257195e-05,-0.26708946,-0.023537183
Essential fructosuria,0.0,2.0,0.0,-0.26813588,-0.024293775
Essential pentosuria,0.0,2.0,0.0,-0.26813588,-0.024293775
Establishment of Sister Chromatid Cohesion,0.00055405626,2.0,0.00055405626,-0.25887004,-0.01759436
Estrogen-dependent gene expression,0.020971665,2.0,0.020971665,0.08258654,0.22928685
Ethanol oxidation,0.009744313,2.0,0.009744313,-0.10517558,0.09353039
Eukaryotic Translation Termination,0.060834486,2.0,0.060834486,0.7492377,0.7112915
Expression and Processing of Neurotrophins,0.032665852,2.0,0.032665852,0.27815583,0.37068808
Extension of Telomeres,0.029380968,3.0,0.029380968,0.22322063,-0.27354574
Extrinsic Pathway of Fibrin Clot Formation,0.002754842,2.0,0.002754842,-0.22206491,0.009016616
FBXW7 Mutants and NOTCH1 in Cancer,0.00097069336,2.0,0.00097069336,-0.25190237,-0.012556554
FCERI mediated Ca+2 mobilization,0.0010048695,2.0,0.0010048695,-0.25133082,-0.012143334
FCERI mediated MAPK activation,0.0024248112,2.0,0.0024248112,-0.22758423,0.005026018
FCERI mediated NF-kB activation,0.0191721,2.0,0.0191721,0.052491285,0.20752728
FCGR activation,0.00527032,2.0,0.00527032,-0.17999698,0.039432734
FMO oxidises nucleophiles,2.3642715e-06,2.0,2.3642715e-06,-0.26809636,-0.024265204
Fanconi Anemia Pathway,0.0027599442,2.0,0.0027599442,-0.22197957,0.009078322
FasL/ CD95L signaling,0.00024890027,2.0,0.00024890027,-0.26397336,-0.021284187
Fatty acyl-CoA biosynthesis,0.05840059,2.0,0.05840059,0.7085341,0.6818618
Fibronectin matrix formation,1.383344e-10,2.0,1.383344e-10,-0.26813588,-0.024293775
Formation of ATP by chemiosmotic coupling,0.0,2.0,0.0,-0.26813588,-0.024293775
Formation of Incision Complex in GG-NER,0.009695918,2.0,0.009695918,-0.105984904,0.092945226
Formation of RNA Pol II elongation complex ,0.13567844,2.0,0.13567844,2.0009005,1.6162734
Formation of TC-NER Pre-Incision Complex,0.024790231,2.0,0.024790231,0.14644684,0.27545938
Formation of editosomes by ADAR proteins,0.0018476644,2.0,0.0018476644,-0.23723622,-0.0019525945
Formation of selenosugars for excretion,0.0,2.0,0.0,-0.26813588,-0.024293775
Formation of the Early Elongation Complex,0.390366,2.0,0.390366,6.2602015,4.6958494
Formation of the Editosome,0.00051986024,2.0,0.00051986024,-0.2594419,-0.018007837
Formation of the beta-catenin:TCF transactivating complex,9.355911e-05,2.0,9.355911e-05,-0.26657122,-0.023162503
Formation of the cornified envelope,0.00013278595,2.0,0.00013278595,-0.26591522,-0.022688186
Formation of xylulose-5-phosphate,0.001211312,2.0,0.001211312,-0.24787834,-0.009647106
Free fatty acids regulate insulin secretion,0.008348602,2.0,0.008348602,-0.12851693,0.07665404
Fructose biosynthesis,0.0011133627,2.0,0.0011133627,-0.24951641,-0.01083146
Fructose catabolism,0.00051538186,2.0,0.00051538186,-0.2595168,-0.018061986
G alpha (12/13) signalling events,0.018878369,2.0,0.018878369,0.047579024,0.20397557
G alpha (i) signalling events,0.13531922,2.0,0.13531922,1.994893,1.6119298
G alpha (q) signalling events,0.011755791,2.0,0.011755791,-0.071536355,0.11785234
G alpha (s) signalling events,0.085747354,2.0,0.085747354,1.1658714,1.0125275
G alpha (z) signalling events,0.009406686,2.0,0.009406686,-0.11082192,0.089447945
G protein gated Potassium channels,0.0062443907,2.0,0.0062443907,-0.16370697,0.051210802
G-protein beta:gamma signalling,0.36556944,3.0,0.36556944,5.8455133,3.7915053
G0 and Early G1,0.009935304,3.0,0.009935304,-0.10198151,-0.5086746
G1 Phase,0.047199506,2.0,0.047199506,0.5212113,0.546423
G1/S Transition,0.012274582,4.0,0.012274582,-0.06286028,-1.0849034
G2 Phase,0.0037202565,2.0,0.0037202565,-0.20591967,0.020690015
G2/M DNA damage checkpoint,0.0005583273,2.0,0.0005583273,-0.25879863,-0.017542716
G2/M DNA replication checkpoint,0.00050792535,2.0,0.00050792535,-0.25964153,-0.01815217
G2/M Transition,0.017445203,9.0,0.0019383559,-0.23571952,-4.0449543
GAB1 signalosome,0.78079635,2.0,0.78079635,12.789616,9.416771
GABA receptor activation,0.0001816875,4.0,0.0001816875,-0.26509738,-1.2311256
"GABA synthesis, release, reuptake and degradation",0.00012161047,4.0,0.00012161047,-0.2661021,-1.231852
GLI proteins bind promoters of Hh responsive genes to promote transcription,0.00061439985,2.0,0.00061439985,-0.25786087,-0.016864724
GLI3 is processed to GLI3R by the proteasome,0.013924185,2.0,0.013924185,-0.035272922,0.14407167
GP1b-IX-V activation signalling,4.8970296e-06,2.0,4.8970296e-06,-0.26805398,-0.024234574
GPVI-mediated activation cascade,0.014686788,2.0,0.014686788,-0.022519425,0.15329273
GRB2 events in EGFR signaling,0.16767332,2.0,0.16767332,2.5359712,2.003142
GRB2 events in ERBB2 signaling,0.0980069,2.0,0.0980069,1.3708954,1.1607648
GRB2:SOS provides linkage to MAPK signaling for Integrins ,0.0062654507,2.0,0.0062654507,-0.16335478,0.05146544
GRB7 events in ERBB2 signaling,0.01502162,2.0,0.01502162,-0.01691982,0.15734139
Galactose catabolism,0.00017540394,2.0,0.00017540394,-0.2652025,-0.022172872
"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",0.00059042324,4.0,0.00059042324,-0.25826186,-1.2261833
Gap junction trafficking,0.00012012431,3.0,0.00012012431,-0.26612696,-0.6273557
Gap-filling DNA repair synthesis and ligation in GG-NER,0.00034829986,2.0,0.00034829986,-0.26231104,-0.020082293
Gap-filling DNA repair synthesis and ligation in TC-NER,0.010496891,2.0,0.010496891,-0.09258973,0.10263025
Generation of second messenger molecules,0.0012286784,2.0,0.0012286784,-0.24758792,-0.009437103
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,0.024516895,2.0,0.024516895,0.14187567,0.2721543
Gluconeogenesis,0.0073132617,2.0,0.0073132617,-0.14583157,0.06413514
Glucuronidation,1.0769314e-05,2.0,1.0769314e-05,-0.26795578,-0.024163555
Glutamate Neurotransmitter Release Cycle,0.0005359892,2.0,0.0005359892,-0.2591722,-0.017812822
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.0002921068,3.0,0.0002921068,-0.26325077,-0.62527615
Glutathione conjugation,1.0437777e-05,2.0,1.0437777e-05,-0.26796132,-0.024167556
Glycerophospholipid biosynthesis,0.0072227907,19.0,0.00038014687,-0.26177844,-10.213703
Glycine degradation,8.375679e-05,2.0,8.375679e-05,-0.26673514,-0.023281025
Glycogen breakdown (glycogenolysis),0.017616082,2.0,0.017616082,0.026469003,0.18871254
Glycogen storage diseases,0.0035967587,10.0,0.00035967588,-0.26212078,-4.8169184
Glycogen synthesis,0.009933245,2.0,0.009933245,-0.102015935,0.09581488
Glycolysis,0.014903834,2.0,0.014903834,-0.018889632,0.15591717
Glycoprotein hormones,1.0383815e-09,2.0,1.0383815e-09,-0.26813585,-0.024293752
Glycosphingolipid metabolism,0.06446705,2.0,0.06446705,0.80998737,0.7552149
Golgi-to-ER retrograde transport,9.414746e-05,3.0,9.414746e-05,-0.2665614,-0.6276698
Growth hormone receptor signaling,0.00020689942,2.0,0.00020689942,-0.26467577,-0.021792037
HATs acetylate histones,0.0037909884,2.0,0.0037909884,-0.20473677,0.021545272
HCN channels,0.0022979232,2.0,0.0022979232,-0.22970626,0.0034917512
HDACs deacetylate histones,0.022385957,2.0,0.022385957,0.10623863,0.24638788
HDL assembly,0.023586456,2.0,0.023586456,0.12631534,0.2609038
HDL clearance,2.0856925e-05,2.0,2.0856925e-05,-0.2677871,-0.024041593
HDL remodeling,0.00028440732,2.0,0.00028440732,-0.26337954,-0.020854844
HDMs demethylate histones,0.00020530593,2.0,0.00020530593,-0.2647024,-0.021811295
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),0.05050752,4.0,0.05050752,0.5765333,-0.6226066
HDR through MMEJ (alt-NHEJ),0.0025888444,2.0,0.0025888444,-0.224841,0.007009436
HHAT G278V abrogates palmitoylation of Hh-Np,0.0,2.0,0.0,-0.26813588,-0.024293775
HIV Life Cycle,0.0007161834,3.0,0.0007161834,-0.25615868,-0.62014836
HSF1 activation,6.187958e-05,2.0,6.187958e-05,-0.26710105,-0.023545561
HSF1-dependent transactivation,0.0021028249,2.0,0.0021028249,-0.232969,0.0011327051
HSP90 chaperone cycle for steroid hormone receptors (SHR),2.2191012e-05,2.0,2.2191012e-05,-0.26776475,-0.024025448
Heme biosynthesis,0.00825278,2.0,0.00825278,-0.13011941,0.0754954
Heme degradation,0.003071961,2.0,0.003071961,-0.21676153,0.01285109
Heparan sulfate/heparin (HS-GAG) metabolism,0.016716082,4.0,0.016716082,0.01141773,-1.0311985
Hereditary fructose intolerance,0.0,2.0,0.0,-0.26813588,-0.024293775
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,0.01074394,2.0,0.01074394,-0.088458166,0.10561746
Histidine catabolism,0.024891231,2.0,0.024891231,0.14813593,0.27668062
Host Interactions of HIV factors,0.0013764275,8.0,0.0013764275,-0.24511701,-3.6347368
Host Interactions with Influenza Factors,0.0037395281,3.0,0.0037395281,-0.20559737,-0.58359134
HuR (ELAVL1) binds and stabilizes mRNA,0.00805203,2.0,0.00805203,-0.13347669,0.073068015
Hyaluronan metabolism,0.004175138,3.0,0.004175138,-0.1983124,-0.57832414
Hypusine synthesis from eIF5A-lysine,0.0033537487,2.0,0.0033537487,-0.21204902,0.01625835
IGF1R signaling cascade,0.0045309262,2.0,0.0045309262,-0.19236234,0.03049229
IKBKB deficiency causes SCID,0.00064295117,2.0,0.00064295117,-0.25738338,-0.016519481
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),0.00038937805,2.0,0.00038937805,-0.26162404,-0.019585581
IP3 and IP4 transport between cytosol and nucleus,0.0,2.0,0.0,-0.26813588,-0.024293775
IP6 and IP7 transport between cytosol and nucleus,0.0,2.0,0.0,-0.26813588,-0.024293775
IPs transport between ER lumen and cytosol,0.0,2.0,0.0,-0.26813588,-0.024293775
IPs transport between ER lumen and nucleus,0.0,2.0,0.0,-0.26813588,-0.024293775
IPs transport between cytosol and ER lumen,0.0,2.0,0.0,-0.26813588,-0.024293775
IPs transport between nucleus and ER lumen,0.0,2.0,0.0,-0.26813588,-0.024293775
IPs transport between nucleus and cytosol,0.0,2.0,0.0,-0.26813588,-0.024293775
IRAK4 deficiency (TLR2/4),1.1416206e-05,2.0,1.1416206e-05,-0.26794496,-0.02415574
IRAK4 deficiency (TLR5),0.00046255943,2.0,0.00046255943,-0.2604002,-0.018700687
IkBA variant leads to EDA-ID,0.00056555215,2.0,0.00056555215,-0.25867778,-0.017455364
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,0.0060759704,2.0,0.0060759704,-0.16652358,0.049174324
Import of palmitoyl-CoA into the mitochondrial matrix,0.0011782753,2.0,0.0011782753,-0.24843082,-0.010046567
Inactivation of CDC42 and RAC1,0.00024832896,2.0,0.00024832896,-0.2639829,-0.02129109
Inflammasomes,0.030617982,5.0,0.030617982,0.243908,-1.467617
Influenza Life Cycle,0.07225323,7.0,0.07225323,0.94020057,-2.1732097
Inhibition of TSC complex formation by PKB,0.0016664527,2.0,0.0016664527,-0.24026673,-0.004143734
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,0.06385949,2.0,0.06385949,0.7998268,0.7478686
Initial triggering of complement,5.4566044e-05,3.0,5.4566044e-05,-0.26722333,-0.6281484
InlA-mediated entry of Listeria monocytogenes into host cells,0.088335454,2.0,0.088335454,1.2091538,1.0438217
InlB-mediated entry of Listeria monocytogenes into host cell,0.014855936,2.0,0.014855936,-0.01969066,0.155338
Inositol transporters,0.0040582097,2.0,0.0040582097,-0.20026787,0.024776401
Insulin effects increased synthesis of Xylulose-5-Phosphate,0.01100313,2.0,0.01100313,-0.084123574,0.108751476
Insulin processing,0.10788508,2.0,0.10788508,1.5360945,1.2802076
Insulin receptor recycling,0.22563271,2.0,0.22563271,3.5052626,2.703963
Insulin receptor signalling cascade,0.023144824,4.0,0.023144824,0.11892966,-0.9534649
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,0.001912074,2.0,0.001912074,-0.23615906,-0.0011737728
Integrin cell surface interactions,0.16647707,2.0,0.16647707,2.5159655,1.9886776
Interaction With Cumulus Cells,0.0,2.0,0.0,-0.26813588,-0.024293775
Interaction With The Zona Pellucida,0.00037164314,2.0,0.00037164314,-0.26192066,-0.019800043
Interaction between L1 and Ankyrins,0.0015707156,2.0,0.0015707156,-0.24186781,-0.005301331
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,0.018440504,2.0,0.018440504,0.04025633,0.1986811
Interconversion of nucleotide di- and triphosphates,0.013231193,2.0,0.013231193,-0.04686227,0.13569228
Interconversion of polyamines,0.0,2.0,0.0,-0.26813588,-0.024293775
Interferon alpha/beta signaling,0.002224727,2.0,0.002224727,-0.23093037,0.0026066818
Interferon gamma signaling,1.3711976e-06,2.0,1.3711976e-06,-0.26811296,-0.024277208
Interleukin-1 family signaling,0.00018285945,7.0,0.00018285945,-0.2650778,-3.0446544
Interleukin-10 signaling,9.693553e-06,2.0,9.693553e-06,-0.26797378,-0.024176566
Interleukin-12 family signaling,6.004061e-05,5.0,6.004061e-05,-0.26713178,-1.8371109
Interleukin-17 signaling,7.836307e-05,2.0,7.836307e-05,-0.26682535,-0.02334624
Interleukin-2 family signaling,6.579827e-06,6.0,6.579827e-06,-0.26802582,-2.4422717
Interleukin-20 family signaling,4.6853984e-05,2.0,4.6853984e-05,-0.26735228,-0.023727238
"Interleukin-3, Interleukin-5 and GM-CSF signaling",0.00041364942,3.0,0.00041364942,-0.26121816,-0.62380654
Interleukin-4 and Interleukin-13 signaling,0.00035320577,2.0,0.00035320577,-0.262229,-0.020022951
Interleukin-6 family signaling,0.0003629611,3.0,0.0003629611,-0.26206586,-0.6244194
Interleukin-7 signaling,0.00022847852,2.0,0.00022847852,-0.2643149,-0.021531127
Intestinal hexose absorption,1.1085761e-08,2.0,1.1085761e-08,-0.2681357,-0.024293635
Intestinal infectious diseases,0.00016525117,2.0,0.00016525117,-0.26537228,-0.022295628
Intestinal lipid absorption,8.98104e-06,2.0,8.98104e-06,-0.26798567,-0.024185177
Intestinal saccharidase deficiencies,0.0,2.0,0.0,-0.26813588,-0.024293775
Intra-Golgi traffic,7.85403e-05,2.0,7.85403e-05,-0.2668224,-0.02334411
Intracellular oxygen transport,2.9918354e-09,2.0,2.9918354e-09,-0.26813582,-0.024293728
Intraflagellar transport,0.000111013884,2.0,0.000111013884,-0.2662793,-0.02295146
Intrinsic Pathway of Fibrin Clot Formation,0.0073226807,2.0,0.0073226807,-0.14567406,0.06424902
Invadopodia formation,0.0006216917,2.0,0.0006216917,-0.25773895,-0.016776554
Ion homeostasis,0.031071283,2.0,0.031071283,0.25148883,0.35140723
Ion influx/efflux at host-pathogen interface,0.0017299021,2.0,0.0017299021,-0.23920563,-0.0033765303
Ion transport by P-type ATPases,0.059382413,2.0,0.059382413,0.7249538,0.69373363
Josephin domain DUBs,0.00044597965,2.0,0.00044597965,-0.2606775,-0.018901179
KSRP (KHSRP) binds and destabilizes mRNA,0.014616227,2.0,0.014616227,-0.023699472,0.15243953
Keratan sulfate/keratin metabolism,0.061023638,3.0,0.061023638,0.752401,0.10906424
Kinesins,0.011915116,2.0,0.011915116,-0.06887186,0.119778834
L13a-mediated translational silencing of Ceruloplasmin expression,0.00694634,2.0,0.00694634,-0.15196784,0.059698466
LDL clearance,3.68231e-05,2.0,3.68231e-05,-0.26752007,-0.023848545
LDL remodeling,0.0,2.0,0.0,-0.26813588,-0.024293775
LGI-ADAM interactions,0.000107490836,2.0,0.000107490836,-0.26633823,-0.022994047
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,0.0011817472,2.0,0.0011817472,-0.24837278,-0.010004575
Lactose synthesis,0.00031756837,2.0,0.00031756837,-0.26282498,-0.020453885
Lagging Strand Synthesis,0.055444803,3.0,0.055444803,0.6591026,0.041607283
Laminin interactions,0.005049879,2.0,0.005049879,-0.18368356,0.036767256
Leading Strand Synthesis,0.0014970166,2.0,0.0014970166,-0.24310033,-0.0061924723
Ligand-receptor interactions,2.4819019e-05,2.0,2.4819019e-05,-0.2677208,-0.023993671
Lipid particle organization,0.005663515,2.0,0.005663515,-0.17342134,0.044187084
Localization of the PINCH-ILK-PARVIN complex to focal adhesions,0.0,2.0,0.0,-0.26813588,-0.024293775
Loss of Function of SMAD2/3 in Cancer,0.0019735475,3.0,0.0019735475,-0.235131,-0.6049449
Loss of Function of SMAD4 in Cancer,0.00038702265,2.0,0.00038702265,-0.26166347,-0.01961406
Loss of Function of TGFBR1 in Cancer,0.0003882815,3.0,0.0003882815,-0.2616424,-0.62411326
Loss of Function of TGFBR2 in Cancer,0.0002884551,3.0,0.0002884551,-0.26331186,-0.6253203
Lysine catabolism,0.019761361,2.0,0.019761361,0.062345866,0.21465236
Lysosomal oligosaccharide catabolism,0.00014133469,2.0,0.00014133469,-0.26577225,-0.022584828
MAPK6/MAPK4 signaling,0.19061066,2.0,0.19061066,2.9195669,2.2804909
MET Receptor Activation,0.016935553,2.0,0.016935553,0.015088094,0.18048386
MET activates PI3K/AKT signaling,0.048103034,2.0,0.048103034,0.5363216,0.5573481
MET activates PTPN11,0.0037579385,2.0,0.0037579385,-0.20528948,0.021145647
MET activates RAS signaling,0.16032316,2.0,0.16032316,2.4130497,1.9142672
MET activates STAT3,0.05733641,2.0,0.05733641,0.6907371,0.6689942
MET promotes cell motility,0.08220984,4.0,0.08220984,1.1067113,-0.23927537
MET receptor recycling,0.023157712,2.0,0.023157712,0.11914519,0.2557196
MGMT-mediated DNA damage reversal,0.002740381,2.0,0.002740381,-0.22230674,0.008841772
MHC class II antigen presentation,0.011807641,2.0,0.011807641,-0.07066923,0.11847929
MTF1 activates gene expression,0.0042405967,2.0,0.0042405967,-0.1972177,0.026981743
Macroautophagy,0.0031435853,2.0,0.0031435853,-0.21556371,0.013717147
Major pathway of rRNA processing in the nucleolus and cytosol,0.026764307,2.0,0.026764307,0.17946056,0.29932907
Meiotic recombination,0.01644096,2.0,0.01644096,0.0068166903,0.17450345
Meiotic synapsis,8.361829e-05,2.0,8.361829e-05,-0.2667375,-0.023282709
Melanin biosynthesis,4.5232668e-05,2.0,4.5232668e-05,-0.26737943,-0.023746848
Metabolism of Angiotensinogen to Angiotensins,0.005661088,2.0,0.005661088,-0.17346191,0.04415774
Metabolism of folate and pterines,0.0012041974,2.0,0.0012041974,-0.24799733,-0.0097331125
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,2.0898273e-05,2.0,2.0898273e-05,-0.26778638,-0.024041079
Metabolism of ingested MeSeO2H into MeSeH,0.007394183,2.0,0.007394183,-0.14447828,0.06511361
"Metabolism of ingested SeMet, Sec, MeSec into H2Se",0.05376401,2.0,0.05376401,0.6309937,0.6257983
Metabolism of steroid hormones,0.079134114,6.0,0.079134114,1.055274,-1.4854945
Metabolism of vitamin K,0.0015271901,2.0,0.0015271901,-0.2425957,-0.005827632
Metal ion SLC transporters,0.0010847286,2.0,0.0010847286,-0.24999528,-0.01117771
Metal sequestration by antimicrobial proteins,1.27391295e-05,2.0,1.27391295e-05,-0.26792285,-0.024139756
Metalloprotease DUBs,0.00013713755,2.0,0.00013713755,-0.26584244,-0.022635583
Metallothioneins bind metals,4.6066566e-06,2.0,4.6066566e-06,-0.26805884,-0.024238084
Methionine salvage pathway,0.004258462,3.0,0.004258462,-0.19691892,-0.5773166
Methylation,3.611342e-05,2.0,3.611342e-05,-0.26753193,-0.02385711
Methylation of MeSeH for excretion,0.008269226,2.0,0.008269226,-0.12984438,0.07569426
MicroRNA (miRNA) biogenesis,0.0042417804,2.0,0.0042417804,-0.1971979,0.026996065
Miscellaneous transport and binding events,0.00029832986,2.0,0.00029832986,-0.2631467,-0.020686481
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),0.00030199505,2.0,0.00030199505,-0.26308542,-0.020642186
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),0.00012828005,2.0,0.00012828005,-0.26599056,-0.02274266
Misspliced GSK3beta mutants stabilize beta-catenin,0.00011507121,2.0,0.00011507121,-0.26621148,-0.02290239
Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling,8.7522436e-05,2.0,8.7522436e-05,-0.2666722,-0.023235511
Mitochondrial ABC transporters,1.3205019e-05,2.0,1.3205019e-05,-0.26791504,-0.024134118
Mitochondrial Fatty Acid Beta-Oxidation,0.01675115,4.0,0.01675115,0.012004194,-1.0307746
Mitochondrial Uncoupling Proteins,0.0019191098,3.0,0.0019191098,-0.2360414,-0.6056031
Mitochondrial protein import,0.00068270485,2.0,0.00068270485,-0.25671858,-0.0160388
Mitochondrial tRNA aminoacylation,0.10862323,2.0,0.10862323,1.548439,1.2891331
Mitochondrial transcription initiation,0.0060271914,2.0,0.0060271914,-0.16733934,0.048584513
Mitochondrial transcription termination,0.005666845,2.0,0.005666845,-0.17336565,0.044227343
Mitochondrial translation elongation,0.0032606118,2.0,0.0032606118,-0.21360661,0.015132179
Mitochondrial translation initiation,0.0027710781,2.0,0.0027710781,-0.2217934,0.009212931
Mitochondrial translation termination,0.0011094074,2.0,0.0011094074,-0.24958256,-0.01087929
Mitotic Metaphase and Anaphase,0.0016890307,3.0,0.0016890307,-0.23988914,-0.60838515
Mitotic Prometaphase,0.024070822,4.0,0.024070822,0.1344157,-0.94226813
Mitotic Prophase,0.02086816,5.0,0.02086816,0.080855556,-1.5855079
Mitotic Telophase/Cytokinesis,0.015913546,2.0,0.015913546,-0.0020035803,0.16812618
Molecules associated with elastic fibres,0.0068727587,2.0,0.0068727587,-0.15319839,0.05880875
Molybdenum cofactor biosynthesis,0.019318732,2.0,0.019318732,0.054943487,0.20930026
Mucopolysaccharidoses,0.0,12.0,0.0,-0.26813588,-6.0694375
Multifunctional anion exchangers,0.00013475181,2.0,0.00013475181,-0.26588234,-0.022664435
MyD88 deficiency (TLR2/4),0.00012149824,2.0,0.00012149824,-0.26610398,-0.022824679
MyD88 deficiency (TLR5),1.14536e-05,2.0,1.14536e-05,-0.26794434,-0.024155295
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,0.010391438,2.0,0.010391438,-0.09435328,0.10135516
NADPH regeneration,0.11419094,2.0,0.11419094,1.6415515,1.3564556
NCAM1 interactions,0.00065907795,2.0,0.00065907795,-0.2571137,-0.01632449
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,0.005594444,2.0,0.005594444,-0.17457646,0.043351904
NFG and proNGF binds to p75NTR,0.001222971,2.0,0.001222971,-0.24768336,-0.00950612
NIK-->noncanonical NF-kB signaling,0.008328275,2.0,0.008328275,-0.12885687,0.07640825
NOD1/2 Signaling Pathway,0.014075567,2.0,0.014075567,-0.032741267,0.14590211
NOSIP mediated eNOS trafficking,0.0,2.0,0.0,-0.26813588,-0.024293775
NOSTRIN mediated eNOS trafficking,0.0030368394,2.0,0.0030368394,-0.21734889,0.012426427
NOTCH1 Intracellular Domain Regulates Transcription,0.03008743,2.0,0.03008743,0.23503524,0.3395109
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.0250855,2.0,0.0250855,0.1513848,0.2790296
NOTCH2 intracellular domain regulates transcription,0.0061749914,2.0,0.0061749914,-0.1648676,0.050371643
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.0015358845,2.0,0.0015358845,-0.24245031,-0.0057224957
NOTCH3 Intracellular Domain Regulates Transcription,0.05706834,2.0,0.05706834,0.6862541,0.6657528
NOTCH4 Activation and Transmission of Signal to the Nucleus,9.380281e-05,2.0,9.380281e-05,-0.26656714,-0.023159554
NOTCH4 Intracellular Domain Regulates Transcription,0.0018952355,2.0,0.0018952355,-0.23644064,-0.001377376
NR1D1 (REV-ERBA) represses gene expression,9.667026e-08,2.0,9.667026e-08,-0.26813427,-0.024292605
Na+/Cl- dependent neurotransmitter transporters,0.00010079972,2.0,0.00010079972,-0.26645017,-0.023074964
Neddylation,0.010238172,2.0,0.010238172,-0.09691646,0.09950193
Negative regulation of MET activity,0.072818205,2.0,0.072818205,0.94964904,0.8561936
Negative regulation of NOTCH4 signaling,0.00073715905,2.0,0.00073715905,-0.2558079,-0.01538037
Negative regulation of TCF-dependent signaling by DVL-interacting proteins,0.00024246407,2.0,0.00024246407,-0.264081,-0.021362014
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,0.0018602186,2.0,0.0018602186,-0.23702627,-0.0018007988
Negative regulation of the PI3K/AKT network,0.118397236,2.0,0.118397236,1.711896,1.4073163
Negative regulators of DDX58/IFIH1 signaling,0.0045172013,2.0,0.0045172013,-0.19259186,0.030326338
Nephrin family interactions,0.00025117764,2.0,0.00025117764,-0.26393527,-0.021256644
Netrin mediated repulsion signals,5.7924157e-05,2.0,5.7924157e-05,-0.26716718,-0.02359339
Neurexins and neuroligins,0.007571605,2.0,0.007571605,-0.14151114,0.06725891
Neurofascin interactions,4.7720896e-06,2.0,4.7720896e-06,-0.26805606,-0.024236072
Neurophilin interactions with VEGF and VEGFR,2.174438e-09,2.0,2.174438e-09,-0.26813585,-0.024293752
Neurotoxicity of clostridium toxins,0.024070872,9.0,0.0026745414,-0.22340783,-3.9648395
Neutrophil degranulation,0.08055174,2.0,0.08055174,1.0789819,0.94970435
Nicotinate metabolism,0.0039950577,2.0,0.0039950577,-0.201324,0.02401279
NoRC negatively regulates rRNA expression,0.002133486,2.0,0.002133486,-0.23245624,0.0015034428
Nonhomologous End-Joining (NHEJ),0.013108515,2.0,0.013108515,-0.048913885,0.13420892
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),0.01463791,2.0,0.01463791,-0.023336852,0.15270172
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),0.0014661711,2.0,0.0014661711,-0.24361618,-0.0065654446
Norepinephrine Neurotransmitter Release Cycle,4.0225696e-05,2.0,4.0225696e-05,-0.26746315,-0.023807384
Notch-HLH transcription pathway,0.0009940556,2.0,0.0009940556,-0.25151166,-0.01227407
NrCAM interactions,0.0021590695,2.0,0.0021590695,-0.2320284,0.0018127905
Nuclear Receptor transcription pathway,0.0010346177,2.0,0.0010346177,-0.2508333,-0.01178363
Nuclear signaling by ERBB4,0.0051830476,2.0,0.0051830476,-0.18145649,0.03837748
O-glycosylation of TSR domain-containing proteins,0.0011238178,2.0,0.0011238178,-0.24934156,-0.010705043
O-linked glycosylation of mucins,0.00704407,2.0,0.00704407,-0.15033345,0.060880177
Oncogene Induced Senescence,0.0124685345,2.0,0.0124685345,-0.05961669,0.12647054
Orc1 removal from chromatin,0.0009890393,2.0,0.0009890393,-0.25159556,-0.012334745
Organic anion transporters,0.00495415,2.0,0.00495415,-0.1852845,0.035609737
Organic cation/anion/zwitterion transport,0.000120458404,3.0,0.000120458404,-0.26612136,-0.62735164
Other interleukin signaling,5.5137752e-05,2.0,5.5137752e-05,-0.26721376,-0.023627087
Other semaphorin interactions,0.0009017702,2.0,0.0009017702,-0.253055,-0.013389945
Ovarian tumor domain proteases,0.0007961582,2.0,0.0007961582,-0.2548212,-0.0146669755
Oxidative Stress Induced Senescence,0.02212759,2.0,0.02212759,0.101917796,0.2432638
PCP/CE pathway,0.0019163227,4.0,0.0019163227,-0.236088,-1.2101511
PD-1 signaling,0.0008405199,2.0,0.0008405199,-0.25407934,-0.014130554
PECAM1 interactions,0.00015410769,2.0,0.00015410769,-0.26555863,-0.022430364
PI Metabolism,0.26322928,14.0,0.018802091,0.04630339,-4.0956073
PI3K events in ERBB2 signaling,0.005594681,2.0,0.005594681,-0.17457248,0.043354772
PI3K events in ERBB4 signaling,0.00010436741,2.0,0.00010436741,-0.26639047,-0.023031814
PIWI-interacting RNA (piRNA) biogenesis,0.005791409,2.0,0.005791409,-0.17128249,0.04573352
PKA activation in glucagon signalling,0.037038513,2.0,0.037038513,0.3512826,0.4235605
PKA-mediated phosphorylation of key metabolic factors,0.5325917,2.0,0.5325917,8.638732,6.4155836
PKMTs methylate histone lysines,0.0029533654,2.0,0.0029533654,-0.21874487,0.011417081
PLCG1 events in ERBB2 signaling,0.037117448,2.0,0.037117448,0.3526027,0.42451492
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",0.0066195102,2.0,0.0066195102,-0.15743361,0.055746585
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",0.0010757513,2.0,0.0010757513,-0.2501454,-0.011286239
PP2A-mediated dephosphorylation of key metabolic factors,0.0067624603,2.0,0.0067624603,-0.15504298,0.05747507
PPARA activates gene expression,0.00025855136,2.0,0.00025855136,-0.26381195,-0.021167468
PRC2 methylates histones and DNA,0.0004042418,2.0,0.0004042418,-0.2613755,-0.019405847
PTEN Loss of Function in Cancer,0.0,2.0,0.0,-0.26813588,-0.024293775
PTEN Regulation,0.31638467,5.0,0.31638467,5.022965,1.987755
PTK6 Activates STAT3,0.0012027826,2.0,0.0012027826,-0.24802098,-0.009750229
PTK6 Down-Regulation,0.00010204514,2.0,0.00010204514,-0.2664293,-0.023059895
PTK6 Expression,0.0008290291,2.0,0.0008290291,-0.2542715,-0.014269503
PTK6 Regulates Cell Cycle,0.00083810184,2.0,0.00083810184,-0.25411978,-0.014159804
PTK6 Regulates Proteins Involved in RNA Processing,0.0043476312,2.0,0.0043476312,-0.19542769,0.028275974
"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",0.0003610694,2.0,0.0003610694,-0.26209748,-0.019927876
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,0.0043219584,2.0,0.0043219584,-0.19585702,0.02796555
PTK6 promotes HIF1A stabilization,0.00079036166,2.0,0.00079036166,-0.25491816,-0.014737058
Packaging Of Telomere Ends,0.0030484828,2.0,0.0030484828,-0.21715416,0.012567213
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.0019741924,2.0,0.0019741924,-0.2351202,-0.00042266844
Passive transport by Aquaporins,0.01197018,2.0,0.01197018,-0.06795099,0.12044464
Pentose phosphate pathway disease,0.0,5.0,0.0,-0.26813588,-1.837837
Peptide chain elongation,0.0023928264,2.0,0.0023928264,-0.22811912,0.004639286
Peroxisomal lipid metabolism,0.0123334965,4.0,0.0123334965,-0.061875015,-1.084191
Phase 0 - rapid depolarisation,0.011423868,2.0,0.011423868,-0.077087305,0.11383887
Phase 1 - inactivation of fast Na+ channels,0.0025020877,2.0,0.0025020877,-0.22629188,0.005960414
Phase 2 - plateau phase,0.03308715,2.0,0.03308715,0.28520146,0.37578225
Phase 3 - rapid repolarisation,0.00041937034,2.0,0.00041937034,-0.2611225,-0.019222928
Phase 4 - resting membrane potential,0.0070279394,2.0,0.0070279394,-0.1506032,0.060685128
Phenylalanine and tyrosine catabolism,0.0022475927,2.0,0.0022475927,-0.23054796,0.0028831642
Phenylketonuria,0.0,2.0,0.0,-0.26813588,-0.024293775
Phosphate bond hydrolysis by NTPDase proteins,0.0029458525,2.0,0.0029458525,-0.21887052,0.011326241
Phosphorylation of CD3 and TCR zeta chains,0.0023663815,2.0,0.0023663815,-0.22856137,0.0043195253
Physiological factors,6.651351e-05,2.0,6.651351e-05,-0.26702353,-0.023489542
Pink/Parkin Mediated Mitophagy,0.0024815963,2.0,0.0024815963,-0.22663456,0.0057126554
Plasmalogen biosynthesis,0.039731648,2.0,0.039731648,0.3963216,0.45612475
Platelet Adhesion to exposed collagen,3.076955e-05,2.0,3.076955e-05,-0.2676213,-0.02392174
Platelet degranulation ,0.20008373,2.0,0.20008373,3.077991,2.3950353
Platelet sensitization by LDL,0.002572293,2.0,0.002572293,-0.2251178,0.0068093077
Post-chaperonin tubulin folding pathway,0.0028172615,2.0,0.0028172615,-0.22102103,0.009771371
Post-transcriptional silencing by small RNAs,0.004190998,2.0,0.004190998,-0.19804716,0.026382025
Post-translational protein phosphorylation,0.0017032118,2.0,0.0017032118,-0.23965198,-0.0036992512
Potassium transport channels,0.013149096,2.0,0.013149096,-0.048235234,0.1346996
Pre-NOTCH Processing in Golgi,0.00090890063,2.0,0.00090890063,-0.25293574,-0.013303739
Pre-NOTCH Processing in the Endoplasmic Reticulum,0.0005421178,2.0,0.0005421178,-0.25906968,-0.017738715
Pre-NOTCH Transcription and Translation,0.007891244,2.0,0.007891244,-0.1361656,0.07112386
Presynaptic depolarization and calcium channel opening,0.00056011096,2.0,0.00056011096,-0.25876877,-0.017521165
Processing and activation of SUMO,0.022160549,4.0,0.022160549,0.102469,-0.96536636
Processing of Intronless Pre-mRNAs,0.00216962,2.0,0.00216962,-0.23185195,0.0019403673
Processing of SMDT1,0.069887646,2.0,0.069887646,0.9006394,0.8207586
Prolactin receptor signaling,0.0014867507,2.0,0.0014867507,-0.243272,-0.006316621
Proline catabolism,1.7210785e-05,2.0,1.7210785e-05,-0.26784804,-0.02408568
Prostacyclin signalling through prostacyclin receptor,0.07835171,2.0,0.07835171,1.0421894,0.9231025
Protein methylation,0.0008399155,2.0,0.0008399155,-0.25408944,-0.014137878
Protein repair,0.035011098,2.0,0.035011098,0.31737685,0.39904583
Proton-coupled monocarboxylate transport,0.0035875544,2.0,0.0035875544,-0.20813894,0.019085431
Proton-coupled neutral amino acid transporters,1.810795e-08,2.0,1.810795e-08,-0.26813558,-0.024293564
Proton/oligopeptide cotransporters,0.00021065984,2.0,0.00021065984,-0.26461288,-0.02174657
Purine catabolism,0.005734889,2.0,0.005734889,-0.1722277,0.04505011
Purine ribonucleoside monophosphate biosynthesis,0.0112641305,2.0,0.0112641305,-0.079758696,0.11190738
Purine salvage,0.011521674,2.0,0.011521674,-0.07545164,0.1150215
Pyrimidine biosynthesis,0.0027445443,2.0,0.0027445443,-0.22223713,0.008892105
Pyrimidine catabolism,0.00012601983,2.0,0.00012601983,-0.26602837,-0.022770016
Pyrimidine salvage,0.020483607,2.0,0.020483607,0.074424446,0.22338547
Pyrophosphate hydrolysis,0.00061211316,2.0,0.00061211316,-0.2578991,-0.01689236
Pyruvate metabolism,0.045684256,2.0,0.045684256,0.49587083,0.5281012
RA biosynthesis pathway,2.4419409e-05,2.0,2.4419409e-05,-0.2677275,-0.023998514
RAB GEFs exchange GTP for GDP on RABs,0.00035198202,2.0,0.00035198202,-0.26224947,-0.020037763
RAB geranylgeranylation,0.0013138562,2.0,0.0013138562,-0.24616343,-0.008407188
RAF-independent MAPK1/3 activation,0.014890579,3.0,0.014890579,-0.019111313,-0.4487575
RAF/MAP kinase cascade,0.025547715,5.0,0.025547715,0.15911472,-1.5289246
RAS signaling downstream of NF1 loss-of-function variants,0.00055717974,2.0,0.00055717974,-0.25881782,-0.017556593
RET signaling,0.003507382,2.0,0.003507382,-0.2094797,0.018116027
RHO GTPases Activate Formins,0.018338226,2.0,0.018338226,0.038545873,0.19744441
RHO GTPases Activate NADPH Oxidases,7.683071e-05,2.0,7.683071e-05,-0.26685098,-0.023364773
RHO GTPases Activate ROCKs,0.00021007191,2.0,0.00021007191,-0.2646227,-0.021753661
RHO GTPases Activate Rhotekin and Rhophilins,2.790466e-06,2.0,2.790466e-06,-0.2680892,-0.024260033
RHO GTPases Activate WASPs and WAVEs,0.0050457586,2.0,0.0050457586,-0.18375246,0.036717422
RHO GTPases activate CIT,0.00021747938,2.0,0.00021747938,-0.26449883,-0.02166411
RHO GTPases activate IQGAPs,0.0032788366,2.0,0.0032788366,-0.21330182,0.015352548
RHO GTPases activate KTN1,0.00226772,2.0,0.00226772,-0.23021136,0.0031265474
RHO GTPases activate PAKs,0.00049407984,2.0,0.00049407984,-0.25987306,-0.018319573
RHO GTPases activate PKNs,0.001110009,2.0,0.001110009,-0.2495725,-0.010872013
RHO GTPases regulate CFTR trafficking,0.00033419652,2.0,0.00033419652,-0.2625469,-0.020252833
RMTs methylate histone arginines,0.009584399,2.0,0.009584399,-0.10784991,0.09159678
RNA Pol II CTD phosphorylation and interaction with CE,0.02637022,2.0,0.02637022,0.17287,0.29456392
RNA Polymerase I Chain Elongation,3.1790692e-05,2.0,3.1790692e-05,-0.26760423,-0.023909384
RNA Polymerase I Promoter Escape,0.023604302,2.0,0.023604302,0.1266138,0.2611196
RNA Polymerase I Promoter Opening,0.0003326565,2.0,0.0003326565,-0.26257265,-0.020271435
RNA Polymerase I Transcription Initiation,0.01144509,2.0,0.01144509,-0.0767324,0.114095464
RNA Polymerase I Transcription Termination,0.0005239196,2.0,0.0005239196,-0.25937405,-0.017958768
RNA Polymerase II Pre-transcription Events,0.07913281,2.0,0.07913281,1.0552522,0.9325472
RNA Polymerase II Promoter Escape,0.002864193,2.0,0.002864193,-0.22023617,0.010338844
RNA Polymerase II Transcription Initiation,0.3757101,2.0,0.3757101,6.015102,4.518636
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,0.1850448,2.0,0.1850448,2.8264852,2.2131908
RNA Polymerase III Abortive And Retractive Initiation,0.00062989286,2.0,0.00062989286,-0.2576018,-0.016677385
RNA Polymerase III Chain Elongation,0.00040290138,2.0,0.00040290138,-0.2613979,-0.019422064
RNA Polymerase III Transcription Initiation From Type 1 Promoter,0.00020061678,2.0,0.00020061678,-0.26478085,-0.021868017
RNA Polymerase III Transcription Initiation From Type 2 Promoter,3.0177465e-05,2.0,3.0177465e-05,-0.2676312,-0.0239289
RNA Polymerase III Transcription Initiation From Type 3 Promoter,4.2485408e-05,2.0,4.2485408e-05,-0.26742536,-0.023780076
RNA Polymerase III Transcription Termination,0.001262095,2.0,0.001262095,-0.24702907,-0.009033055
RNA polymerase II transcribes snRNA genes,0.14583343,2.0,0.14583343,2.170729,1.7390634
RNF mutants show enhanced WNT signaling and proliferation,0.0011838337,2.0,0.0011838337,-0.24833788,-0.0099793505
ROBO receptors bind AKAP5,6.720245e-05,2.0,6.720245e-05,-0.267012,-0.023481188
RORA activates gene expression,5.4230994e-05,2.0,5.4230994e-05,-0.26722893,-0.023638038
"ROS, RNS production in phagocytes",0.006179201,2.0,0.006179201,-0.1647972,0.050422538
Rap1 signalling,0.015033201,2.0,0.015033201,-0.016726144,0.15748142
Receptor Mediated Mitophagy,0.0092690205,2.0,0.0092690205,-0.113124184,0.08778335
Receptor-type tyrosine-protein phosphatases,0.009176809,2.0,0.009176809,-0.11466629,0.08666837
Recognition of DNA damage by PCNA-containing replication complex,0.04552244,2.0,0.04552244,0.4931647,0.5261446
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,0.006330853,2.0,0.006330853,-0.16226101,0.052256264
Recycling pathway of L1,0.0013586289,2.0,0.0013586289,-0.24541466,-0.007865817
Reduction of cytosolic Ca++ levels,0.0030430085,2.0,0.0030430085,-0.21724571,0.012501014
Reelin signalling pathway,0.00035247076,2.0,0.00035247076,-0.2622413,-0.020031866
Regulated proteolysis of p75NTR,0.00013362314,2.0,0.00013362314,-0.26590124,-0.022678077
Regulation of Complement cascade,0.00053224375,2.0,0.00053224375,-0.25923485,-0.017858125
Regulation of FZD by ubiquitination,0.0012666081,2.0,0.0012666081,-0.24695359,-0.008978486
Regulation of HSF1-mediated heat shock response,0.0068761674,2.0,0.0068761674,-0.1531414,0.05884996
Regulation of Hypoxia-inducible Factor (HIF) by oxygen,9.848007e-05,4.0,9.848007e-05,-0.26648894,-1.2321317
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),0.0029399826,2.0,0.0029399826,-0.21896869,0.011255258
Regulation of KIT signaling,0.0785111,2.0,0.0785111,1.0448549,0.92502975
Regulation of PAK-2p34 activity by PS-GAP/RHG10,0.00053727685,2.0,0.00053727685,-0.25915065,-0.017797261
Regulation of TLR by endogenous ligand,0.033302907,2.0,0.033302907,0.2888097,0.3783911
Regulation of TNFR1 signaling,0.0036651941,2.0,0.0036651941,-0.20684052,0.020024214
Regulation of actin dynamics for phagocytic cup formation,0.027869847,2.0,0.027869847,0.1979492,0.31269678
Regulation of activated PAK-2p34 by proteasome mediated degradation,0.0034012913,2.0,0.0034012913,-0.21125393,0.016833218
Regulation of cholesterol biosynthesis by SREBP (SREBF),0.12944347,2.0,0.12944347,1.8966291,1.5408827
Regulation of commissural axon pathfinding by SLIT and ROBO,0.00018583507,2.0,0.00018583507,-0.26502806,-0.022046745
Regulation of cortical dendrite branching,6.8809377e-06,2.0,6.8809377e-06,-0.2680208,-0.024210589
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,0.0065762307,2.0,0.0065762307,-0.15815741,0.055223268
Regulation of expression of SLITs and ROBOs,0.00062355876,2.0,0.00062355876,-0.25770772,-0.01675395
Regulation of gap junction activity,7.0256436e-05,2.0,7.0256436e-05,-0.26696092,-0.023444263
Regulation of gene expression in early pancreatic precursor cells,8.929665e-08,2.0,8.929665e-08,-0.2681344,-0.0242927
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,5.470573e-07,2.0,5.470573e-07,-0.26812673,-0.024287153
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,4.6982495e-06,2.0,4.6982495e-06,-0.26805732,-0.024236985
Regulation of innate immune responses to cytosolic DNA,0.0,2.0,0.0,-0.26813588,-0.024293775
Regulation of necroptotic cell death,0.000509005,2.0,0.000509005,-0.25962347,-0.018139113
Regulation of ornithine decarboxylase (ODC),0.019960234,2.0,0.019960234,0.06567174,0.21705703
Regulation of signaling by NODAL,7.602099e-05,2.0,7.602099e-05,-0.26686454,-0.023374578
Release of Hh-Np from the secreting cell,0.00013491459,2.0,0.00013491459,-0.2658796,-0.022662446
Release of apoptotic factors from the mitochondria,0.0016537468,2.0,0.0016537468,-0.24047923,-0.0042973547
Repression of WNT target genes,0.0026955057,2.0,0.0026955057,-0.22305723,0.00829915
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,0.0018095205,3.0,0.0018095205,-0.23787412,-0.60692817
Resolution of AP sites via the single-nucleotide replacement pathway,0.00018248733,2.0,0.00018248733,-0.26508403,-0.022087228
Respiratory electron transport,0.025823977,2.0,0.025823977,0.16373482,0.28795898
Response of Mtb to phagocytosis,0.0,5.0,0.0,-0.26813588,-1.837837
Retinoid cycle disease events,0.0004978339,2.0,0.0004978339,-0.2598103,-0.018274177
Retinoid metabolism and transport,0.0065994784,2.0,0.0065994784,-0.15776862,0.05550436
Retinoid metabolism disease events,0.0,2.0,0.0,-0.26813588,-0.024293775
Retrograde transport at the Trans-Golgi-Network,0.0003798573,2.0,0.0003798573,-0.2617833,-0.01970071
Reversible hydration of carbon dioxide,5.9889786e-05,2.0,5.9889786e-05,-0.2671343,-0.023569616
Rhesus glycoproteins mediate ammonium transport.,1.2702202e-07,2.0,1.2702202e-07,-0.26813376,-0.024292255
Rho GTPase cycle,0.014679918,2.0,0.014679918,-0.022634322,0.15320966
Role of ABL in ROBO-SLIT signaling,2.3922816e-05,2.0,2.3922816e-05,-0.2677358,-0.024004528
Role of LAT2/NTAL/LAB on calcium mobilization,0.003849474,2.0,0.003849474,-0.20375869,0.022252455
Role of phospholipids in phagocytosis,0.0030873849,2.0,0.0030873849,-0.21650359,0.0130375875
Role of second messengers in netrin-1 signaling,0.0012683714,2.0,0.0012683714,-0.2469241,-0.008957157
SDK interactions,0.0,2.0,0.0,-0.26813588,-0.024293775
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,0.0009124462,2.0,0.0009124462,-0.25287646,-0.013260847
SHC1 events in EGFR signaling,0.05225769,2.0,0.05225769,0.60580254,0.6075845
SHC1 events in ERBB2 signaling,0.13778211,2.0,0.13778211,2.0360816,1.6417102
SHC1 events in ERBB4 signaling,0.033743333,2.0,0.033743333,0.2961752,0.38371655
SIRT1 negatively regulates rRNA expression,0.03633059,2.0,0.03633059,0.33944353,0.41500053
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,0.017309703,2.0,0.017309703,0.021345234,0.18500793
SLBP independent Processing of Histone Pre-mRNAs,0.0009141586,2.0,0.0009141586,-0.25284782,-0.013240161
SLIT2:ROBO1 increases RHOA activity,5.19092e-06,2.0,5.19092e-06,-0.26804906,-0.024231017
SRP-dependent cotranslational protein targeting to membrane,0.015249311,2.0,0.015249311,-0.013112004,0.16009453
STING mediated induction of host immune responses,1.5728674e-05,3.0,1.5728674e-05,-0.26787284,-0.62861794
SUMO E3 ligases SUMOylate target proteins,0.0012485022,12.0,0.00010404185,-0.26639593,-6.054341
Scavenging by Class A Receptors,0.020745082,2.0,0.020745082,0.07879725,0.2265471
Scavenging by Class B Receptors,0.0016900918,2.0,0.0016900918,-0.23987141,-0.0038579032
Scavenging by Class F Receptors,0.0048668506,2.0,0.0048668506,-0.18674445,0.034554154
Scavenging by Class H Receptors,0.05651647,2.0,0.05651647,0.6770248,0.65907985
Scavenging of heme from plasma,0.009008577,2.0,0.009008577,-0.11747974,0.08463418
SeMet incorporation into proteins,0.0042688875,2.0,0.0042688875,-0.19674458,0.027323827
Selenocysteine synthesis,0.00011029155,2.0,0.00011029155,-0.2662914,-0.022960188
Sema3A PAK dependent Axon repulsion,0.00015324622,2.0,0.00015324622,-0.26557305,-0.0224408
Sema4D in semaphorin signaling,6.945666e-05,3.0,6.945666e-05,-0.26697433,-0.6279683
Senescence-Associated Secretory Phenotype (SASP),0.021883337,2.0,0.021883337,0.09783301,0.2403104
Sensing of DNA Double Strand Breaks,0.00057672075,2.0,0.00057672075,-0.258491,-0.0173203
Serine biosynthesis,0.008325073,2.0,0.008325073,-0.12891042,0.076369524
Serotonin Neurotransmitter Release Cycle,8.7171524e-05,2.0,8.7171524e-05,-0.26667804,-0.023239747
Serotonin and melatonin biosynthesis,0.00028560753,2.0,0.00028560753,-0.2633595,-0.020840336
Serotonin clearance from the synaptic cleft,0.0,2.0,0.0,-0.26813588,-0.024293775
Signal regulatory protein family interactions,7.9810685e-05,2.0,7.9810685e-05,-0.26680115,-0.023328736
Signal transduction by L1,0.0030130765,2.0,0.0030130765,-0.2177463,0.012139087
Signaling by BMP,0.006975181,2.0,0.006975181,-0.1514855,0.06004721
Signaling by BRAF and RAF fusions,0.0054323166,2.0,0.0054323166,-0.1772878,0.041391537
Signaling by EGFRvIII in Cancer,0.013987041,2.0,0.013987041,-0.034221742,0.14483169
Signaling by FGFR1,0.01866545,5.0,0.01866545,0.044018243,-1.6121421
Signaling by FGFR1 in disease,0.0068349014,2.0,0.0068349014,-0.15383148,0.058351003
Signaling by FGFR2,0.6155421,5.0,0.6155421,10.025964,5.6050425
Signaling by FGFR2 in disease,0.0001921982,2.0,0.0001921982,-0.2649216,-0.021969782
Signaling by FGFR3,0.5217292,4.0,0.5217292,8.457071,5.0752096
Signaling by FGFR3 in disease,0.0077785556,3.0,0.0077785556,-0.13805018,-0.53475314
Signaling by FGFR4,0.15194659,4.0,0.15194659,2.272963,0.6039524
Signaling by FGFR4 in disease,1.4921134e-05,2.0,1.4921134e-05,-0.26788634,-0.024113363
Signaling by Hippo,0.042990044,2.0,0.042990044,0.4508138,0.4955239
Signaling by Leptin,0.048024535,2.0,0.048024535,0.5350088,0.55639887
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.0013030999,2.0,0.0013030999,-0.24634331,-0.008537244
Signaling by MST1,0.017604427,2.0,0.017604427,0.026274098,0.18857162
Signaling by NOTCH1 HD Domain Mutants in Cancer,0.0010975512,2.0,0.0010975512,-0.24978083,-0.011022662
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,0.001890516,2.0,0.001890516,-0.23651959,-0.0014344486
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.0019834868,2.0,0.0019834868,-0.23496477,-0.0003102783
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,0.0035440451,2.0,0.0035440451,-0.20886657,0.01855934
Signaling by NTRK1 (TRKA),0.5550176,9.0,0.06166862,0.76318747,2.4551473
Signaling by NTRK2 (TRKB),0.60771686,10.0,0.060771685,0.7481874,2.4878507
Signaling by NTRK3 (TRKC),0.06608192,6.0,0.06608192,0.8369939,-1.6433161
Signaling by Overexpressed Wild-Type EGFR in Cancer,0.00090374507,2.0,0.00090374507,-0.253022,-0.013366077
Signaling by RAS mutants,0.023246577,2.0,0.023246577,0.12063133,0.25679412
Signaling by high-kinase activity BRAF mutants,0.022454781,2.0,0.022454781,0.10738964,0.24722008
Signaling by moderate kinase activity BRAF mutants,0.0008531374,2.0,0.0008531374,-0.2538683,-0.013977986
Small interfering RNA (siRNA) biogenesis,0.00024748815,2.0,0.00024748815,-0.263997,-0.02130127
Smooth Muscle Contraction,0.041600306,2.0,0.041600306,0.42757234,0.47871977
Sodium-coupled phosphate cotransporters,3.4394034e-05,2.0,3.4394034e-05,-0.2675607,-0.023877911
"Sodium-coupled sulphate, di- and tri-carboxylate transporters",0.00010952165,2.0,0.00010952165,-0.26630428,-0.022969501
Sodium/Calcium exchangers,0.0002330758,2.0,0.0002330758,-0.264238,-0.021475527
Sodium/Proton exchangers,8.227117e-06,2.0,8.227117e-06,-0.26799828,-0.024194302
Sperm Motility And Taxes,0.00014466925,2.0,0.00014466925,-0.26571646,-0.022544486
Sperm:Oocyte Membrane Binding,0.0012572587,2.0,0.0012572587,-0.24710995,-0.00909152
Sphingolipid de novo biosynthesis,0.019874439,2.0,0.019874439,0.06423693,0.21601965
Stimulation of the cell death response by PAK-2p34,0.0007734255,2.0,0.0007734255,-0.2552014,-0.014941832
Striated Muscle Contraction,0.019001447,2.0,0.019001447,0.049637333,0.2054638
Surfactant metabolism,0.00019030739,2.0,0.00019030739,-0.26495326,-0.021992669
Synaptic adhesion-like molecules,0.00045910044,2.0,0.00045910044,-0.26045805,-0.018742528
Syndecan interactions,0.00020584084,2.0,0.00020584084,-0.26469347,-0.021804836
"Synthesis of IP2, IP, and Ins in the cytosol",0.018583775,2.0,0.018583775,0.04265234,0.20041347
Synthesis of IP3 and IP4 in the cytosol,0.01529462,2.0,0.01529462,-0.012354275,0.16064239
Synthesis of IPs in the ER lumen,0.0,2.0,0.0,-0.26813588,-0.024293775
Synthesis of IPs in the nucleus,0.0035898425,2.0,0.0035898425,-0.20810068,0.019113101
Synthesis of Ketone Bodies,0.0033128539,2.0,0.0033128539,-0.21273293,0.015763873
Synthesis of Lipoxins (LX),0.005740472,2.0,0.005740472,-0.17213432,0.04511762
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,0.00060878426,2.0,0.00060878426,-0.2579548,-0.016932609
Synthesis of diphthamide-EEF2,0.009102955,2.0,0.009102955,-0.115901396,0.08577536
Synthesis of dolichyl-phosphate mannose,2.9471685e-06,2.0,2.9471685e-06,-0.26808658,-0.024258161
Synthesis of glycosylphosphatidylinositol (GPI),8.9731584e-05,2.0,8.9731584e-05,-0.26663524,-0.023208788
Synthesis of pyrophosphates in the cytosol,0.026636675,2.0,0.026636675,0.17732608,0.2977858
Synthesis of wybutosine at G37 of tRNA(Phe),1.52431985e-05,2.0,1.52431985e-05,-0.26788095,-0.024109455
"Synthesis, secretion, and deacylation of Ghrelin",0.023308307,2.0,0.023308307,0.12166368,0.25754055
"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",0.0004047674,2.0,0.0004047674,-0.2613667,-0.019399505
"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",0.00029765858,2.0,0.00029765858,-0.26315796,-0.020694625
TBC/RABGAPs,0.0010502209,2.0,0.0010502209,-0.25057238,-0.011594955
TCF7L2 mutants don't bind CTBP,9.388863e-05,2.0,9.388863e-05,-0.2665657,-0.023158526
"TET1,2,3 and TDG demethylate DNA",0.00030336846,2.0,0.00030336846,-0.26306245,-0.02062557
TGF-beta receptor signaling activates SMADs,0.00076596526,2.0,0.00076596526,-0.25532615,-0.015032062
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),0.04445722,2.0,0.04445722,0.47535032,0.51326436
TICAM1 deficiency - HSE,0.0023169375,2.0,0.0023169375,-0.22938827,0.0037216677
TLR3 deficiency - HSE,0.00068011717,2.0,0.00068011717,-0.25676185,-0.016070085
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,0.016734323,2.0,0.016734323,0.011722784,0.17805067
TNFR1-induced NFkappaB signaling pathway,0.00016951158,2.0,0.00016951158,-0.26530102,-0.022244124
TNFR1-induced proapoptotic signaling,0.00015077491,2.0,0.00015077491,-0.26561436,-0.022470659
TNFR1-mediated ceramide production,0.00146992,2.0,0.00146992,-0.24355347,-0.0065201307
TNFs bind their physiological receptors,0.009781079,2.0,0.009781079,-0.1045607,0.093974955
TRAF3 deficiency - HSE,0.0006057194,2.0,0.0006057194,-0.25800607,-0.016969673
TRAF3-dependent IRF activation pathway,6.0156195e-05,2.0,6.0156195e-05,-0.26712984,-0.02356641
TRAF6 mediated IRF7 activation,0.00089595444,2.0,0.00089595444,-0.25315225,-0.013460262
TRAF6 mediated NF-kB activation,0.002422939,2.0,0.002422939,-0.22761554,0.00500339
TRAIL  signaling,0.0012233757,2.0,0.0012233757,-0.24767658,-0.00950123
TRP channels,0.02327748,2.0,0.02327748,0.12114815,0.25716782
TWIK related potassium channel (TREK),0.0,2.0,0.0,-0.26813588,-0.024293775
TWIK-related alkaline pH activated K+ channel (TALK),0.0020898855,2.0,0.0020898855,-0.2331854,0.00097625284
TWIK-related spinal cord K+ channel (TRESK),3.0411837e-07,2.0,3.0411837e-07,-0.2681308,-0.024290102
TWIK-releated acid-sensitive K+ channel (TASK),0.0,2.0,0.0,-0.26813588,-0.024293775
TYSND1 cleaves peroxisomal proteins,0.01807262,2.0,0.01807262,0.03410398,0.1942328
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),0.009427609,2.0,0.009427609,-0.11047201,0.08970094
Tandem pore domain halothane-inhibited K+ channel (THIK),0.0,2.0,0.0,-0.26813588,-0.024293775
Terminal pathway of complement,5.4075103e-06,2.0,5.4075103e-06,-0.26804546,-0.024228396
Termination of translesion DNA synthesis,0.022259595,2.0,0.022259595,0.10412541,0.24485996
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",0.005795715,2.0,0.005795715,-0.17121047,0.045785595
The activation of arylsulfatases,0.007375826,2.0,0.007375826,-0.14478527,0.06489164
Threonine catabolism,0.0013199961,2.0,0.0013199961,-0.24606074,-0.008332928
Thrombin signalling through proteinase activated receptors (PARs),0.02166397,2.0,0.02166397,0.09416439,0.23765792
Thromboxane signalling through TP receptor,0.025627386,2.0,0.025627386,0.1604471,0.2855819
Thyroxine biosynthesis,0.002179826,2.0,0.002179826,-0.23168127,0.002063767
Tie2 Signaling,0.0017421917,2.0,0.0017421917,-0.2390001,-0.0032279287
Tight junction interactions,0.003656312,2.0,0.003656312,-0.20698906,0.01991682
Toll Like Receptor 10 (TLR10) Cascade,0.0,1.0,0.0,-0.26813588,0.58022064
Toll Like Receptor 2 (TLR2) Cascade,0.0,1.0,0.0,-0.26813588,0.58022064
Toll Like Receptor 3 (TLR3) Cascade,0.03199303,7.0,0.03199303,0.26690382,-2.6600192
Toll Like Receptor 4 (TLR4) Cascade,0.113313176,3.0,0.113313176,1.6268721,0.7413275
Toll Like Receptor 5 (TLR5) Cascade,0.0,1.0,0.0,-0.26813588,0.58022064
Toll Like Receptor 7/8 (TLR7/8) Cascade,0.01398521,2.0,0.01398521,-0.034252364,0.14480954
Toll Like Receptor 9 (TLR9) Cascade,0.00045323875,2.0,0.00045323875,-0.26055607,-0.018813405
Trafficking and processing of endosomal TLR,0.0051400615,2.0,0.0051400615,-0.18217538,0.037857704
Trafficking of myristoylated proteins to the cilium,0.0023138023,2.0,0.0023138023,-0.2294407,0.003683748
Transcriptional Regulation by E2F6,0.00012201874,2.0,0.00012201874,-0.26609528,-0.022818383
Transcriptional Regulation by TP53,0.0032085767,6.0,0.0032085767,-0.21447682,-2.4035544
Transcriptional activation of mitochondrial biogenesis,0.0008006034,2.0,0.0008006034,-0.25474688,-0.014613202
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,0.013485868,4.0,0.013485868,-0.04260317,-1.070257
Transcriptional regulation by RUNX1,0.0017682036,13.0,0.00013601566,-0.26586118,-6.652571
Transcriptional regulation by RUNX2,0.008396928,5.0,0.008396928,-0.12770873,-1.7363046
Transcriptional regulation by RUNX3,0.0031162098,10.0,0.00031162097,-0.26292446,-4.8227286
Transcriptional regulation by small RNAs,0.002189126,2.0,0.002189126,-0.23152573,0.0021762156
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,3.054473e-05,7.0,3.054473e-05,-0.26762503,-3.0464964
Transcriptional regulation of white adipocyte differentiation,0.012402665,2.0,0.012402665,-0.06071827,0.12567407
Transferrin endocytosis and recycling,0.016779115,2.0,0.016779115,0.012471883,0.17859228
Translesion Synthesis by POLH,0.0029466134,2.0,0.0029466134,-0.2188578,0.011335438
Translesion synthesis by POLI,0.000100629484,2.0,0.000100629484,-0.266453,-0.023077024
Translesion synthesis by POLK,0.011953952,2.0,0.011953952,-0.06822238,0.12024842
Translesion synthesis by REV1,0.0030349507,2.0,0.0030349507,-0.21738046,0.012403589
Translocation of SLC2A4 (GLUT4) to the plasma membrane,6.7811125e-06,2.0,6.7811125e-06,-0.26802245,-0.024211783
Translocation of ZAP-70 to Immunological synapse,0.00028815342,2.0,0.00028815342,-0.2633169,-0.020809565
Transport and synthesis of PAPS,0.00821071,2.0,0.00821071,-0.13082297,0.0749867
Transport of Mature mRNA derived from an Intron-Containing Transcript,0.054137975,2.0,0.054137975,0.63724774,0.6303201
Transport of Mature mRNAs Derived from Intronless Transcripts,0.002478585,4.0,0.002478585,-0.22668494,-1.2033525
Transport of fatty acids,0.00042671416,2.0,0.00042671416,-0.26099965,-0.019134149
Transport of glycerol from adipocytes to the liver by Aquaporins,0.0,2.0,0.0,-0.26813588,-0.024293775
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,0.0022634936,2.0,0.0022634936,-0.23028204,0.003075442
Transport of nucleotide sugars,0.0040896153,2.0,0.0040896153,-0.19974266,0.025156148
Transport of organic anions,1.9718713e-05,2.0,1.9718713e-05,-0.2678061,-0.024055352
Transport to the Golgi and subsequent modification,0.015448587,3.0,0.015448587,-0.009779385,-0.4420103
Triglyceride biosynthesis,0.004387813,2.0,0.004387813,-0.1947557,0.028761826
Triglyceride catabolism,0.0025750794,2.0,0.0025750794,-0.2250712,0.0068430034
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",0.013257304,2.0,0.013257304,-0.046425592,0.13600801
Tryptophan catabolism,0.00028389294,2.0,0.00028389294,-0.26338816,-0.020861069
Type I hemidesmosome assembly,0.00041960055,2.0,0.00041960055,-0.26111862,-0.019220144
UCH proteinases,0.0034667861,2.0,0.0034667861,-0.21015862,0.017625155
UNC93B1 deficiency - HSE,0.0010085247,2.0,0.0010085247,-0.25126967,-0.012099108
Ub-specific processing proteases,0.002004257,2.0,0.002004257,-0.23461743,-5.9149654e-05
Ubiquinol biosynthesis,0.035208307,2.0,0.035208307,0.32067493,0.40143037
Ubiquitin-dependent degradation of Cyclin D,0.03464982,2.0,0.03464982,0.31133497,0.39467737
Unwinding of DNA,0.00014684504,2.0,0.00014684504,-0.26568007,-0.022518184
Uptake and function of anthrax toxins,0.035832014,2.0,0.035832014,0.33110556,0.408972
Uptake and function of diphtheria toxin,0.0012452434,2.0,0.0012452434,-0.24731088,-0.00923681
Urea cycle,0.038334113,2.0,0.038334113,0.37294972,0.43922636
Utilization of Ketone Bodies,0.0018930428,2.0,0.0018930428,-0.23647733,-0.0014039
VEGF ligand-receptor interactions,2.8602078e-06,2.0,2.8602078e-06,-0.26808804,-0.024259191
VEGFA-VEGFR2 Pathway,0.00496958,3.0,0.00496958,-0.18502645,-0.5687181
VLDL assembly,0.0,2.0,0.0,-0.26813588,-0.024293775
VLDL clearance,7.216407e-07,2.0,7.216407e-07,-0.26812384,-0.02428507
VLDLR internalisation and degradation,4.4333126e-05,2.0,4.4333126e-05,-0.26739448,-0.02375773
Variant SLC6A14 may confer susceptibility towards obesity,0.0,2.0,0.0,-0.26813588,-0.024293775
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),0.0,2.0,0.0,-0.26813588,-0.024293775
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),0.0,2.0,0.0,-0.26813588,-0.024293775
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),0.0,2.0,0.0,-0.26813588,-0.024293775
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),0.0,2.0,0.0,-0.26813588,-0.024293775
Vasopressin regulates renal water homeostasis via Aquaporins,0.023841241,2.0,0.023841241,0.13057628,0.2639846
Vitamin B1 (thiamin) metabolism,0.0011099087,2.0,0.0011099087,-0.24957417,-0.010873229
Vitamin B2 (riboflavin) metabolism,0.012059507,2.0,0.012059507,-0.066457115,0.12152475
Vitamin B5 (pantothenate) metabolism,0.004255995,2.0,0.004255995,-0.19696018,0.027167937
Vitamin C (ascorbate) metabolism,0.015695298,2.0,0.015695298,-0.0056534796,0.16548721
Vitamin D (calciferol) metabolism,0.5777326,2.0,0.5777326,9.393652,6.961409
Vitamin E,6.105205e-07,2.0,6.105205e-07,-0.26812565,-0.024286404
Vitamins B6 activation to pyridoxal phosphate,0.0,2.0,0.0,-0.26813588,-0.024293775
Voltage gated Potassium channels,0.0026778819,2.0,0.0026778819,-0.22335196,0.008086057
VxPx cargo-targeting to cilium,0.0013645348,2.0,0.0013645348,-0.2453159,-0.0077944
WNT ligand biogenesis and trafficking,0.051874373,2.0,0.051874373,0.59939206,0.60294956
WNT ligand secretion is abrogated by the PORCN inhibitor LGK974,0.0,2.0,0.0,-0.26813588,-0.024293775
WNT mediated activation of DVL,0.001177675,2.0,0.001177675,-0.24844088,-0.010053832
Wax biosynthesis,8.512482e-05,2.0,8.512482e-05,-0.26671228,-0.02326448
"XAV939 inhibits tankyrase, stabilizing AXIN",2.817819e-05,2.0,2.817819e-05,-0.26766464,-0.023953073
XBP1(S) activates chaperone genes,0.00043415822,2.0,0.00043415822,-0.26087517,-0.01904413
YAP1- and WWTR1 (TAZ)-stimulated gene expression,0.0086632855,2.0,0.0086632855,-0.12325428,0.08045906
ZBP1(DAI) mediated induction of type I IFNs,0.0010515316,3.0,0.0010515316,-0.25055045,-0.61609346
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.02530893,3.0,0.02530893,0.15512136,-0.3227831
cGMP effects,0.00012258063,2.0,0.00012258063,-0.2660859,-0.022811597
eNOS activation,0.000813596,2.0,0.000813596,-0.2545296,-0.014456118
mRNA 3'-end processing,0.09751767,2.0,0.09751767,1.3627138,1.1548493
mRNA Capping,0.0049899076,2.0,0.0049899076,-0.1846865,0.0360421
mRNA Splicing - Major Pathway,0.07975679,2.0,0.07975679,1.0656873,0.9400921
mRNA Splicing - Minor Pathway,0.000796173,2.0,0.000796173,-0.25482097,-0.014666788
mRNA decay by 3' to 5' exoribonuclease,0.13247763,2.0,0.13247763,1.9473712,1.5775706
mRNA decay by 5' to 3' exoribonuclease,0.0076736133,2.0,0.0076736133,-0.13980518,0.06849235
mTORC1-mediated signalling,0.000344051,2.0,0.000344051,-0.2623821,-0.020133656
p130Cas linkage to MAPK signaling for integrins,0.004652472,2.0,0.004652472,-0.19032964,0.031961974
p53-Dependent G1/S DNA damage checkpoint,0.008063927,2.0,0.008063927,-0.13327771,0.07321186
p53-Independent G1/S DNA damage checkpoint,0.012835972,2.0,0.012835972,-0.053471796,0.13091344
p75NTR negatively regulates cell cycle via SC1,0.00020696226,2.0,0.00020696226,-0.26467472,-0.021791289
p75NTR regulates axonogenesis,0.0015558049,3.0,0.0015558049,-0.24211717,-0.609996
p75NTR signals via NF-kB,0.00012811119,3.0,0.00012811119,-0.2659934,-0.6272591
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,0.0025822353,5.0,0.0025822353,-0.22495152,-1.8066136
rRNA modification in the mitochondrion,0.0004284946,2.0,0.0004284946,-0.26096988,-0.019112598
rRNA modification in the nucleus and cytosol,0.03696793,2.0,0.03696793,0.3501022,0.422707
snRNP Assembly,0.07939722,2.0,0.07939722,1.059674,0.9357443
tRNA modification in the mitochondrion,0.00042375468,2.0,0.00042375468,-0.26104915,-0.019169904
tRNA processing in the mitochondrion,1.1824213e-07,2.0,1.1824213e-07,-0.2681339,-0.024292372
tRNA processing in the nucleus,0.0005532464,2.0,0.0005532464,-0.2588836,-0.017604165
truncated APC mutants destabilize the destruction complex,0.001293959,3.0,0.001293959,-0.24649619,-0.61316216
via Death Receptors in the presence of ligand,0.0009162926,3.0,0.0009162926,-0.25281212,-0.6177287
via Dependence Receptors in the absence of ligand,0.05772679,2.0,0.05772679,0.69726574,0.6737145
